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Abstract Mg2+ regulates many physiological processes and signalling pathways. However, little
is known about the mechanisms underlying the organismal balance of Mg2+. Capitalizing on a set of
newly generated mouse models, we provide an integrated mechanistic model of the regulation of
organismal Mg2+ balance during prenatal development and in adult mice by the ion channel
TRPM6. We show that TRPM6 activity in the placenta and yolk sac is essential for embryonic
development. In adult mice, TRPM6 is required in the intestine to maintain organismal Mg2+
balance, but is dispensable in the kidney. Trpm6 inactivation in adult mice leads to a shortened
lifespan, growth deficit and metabolic alterations indicative of impaired energy balance. Dietary
Mg2+ supplementation not only rescues all phenotypes displayed by Trpm6-deficient adult mice,
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but also may extend the lifespan of wildtype mice. Hence, maintenance of organismal Mg2+
balance by TRPM6 is crucial for prenatal development and survival to adulthood.
DOI: 10.7554/eLife.20914.001
Introduction
Mg2+ is the most abundant intracellular divalent cation and is essential for the regulation of a broad
spectrum of metabolic and signalling pathways (de Baaij et al., 2015). In addition, direct association
with Mg2+ fosters the structural integrity of key metabolites (such as ATP), proteins, lipid membranes
and nucleic acids (de Baaij et al., 2015) implying that organismal Mg2+ deficiency, a surprisingly
common condition in humans (King et al., 2005; Rosanoff et al., 2012), may be especially harmful
during prenatal development and early postnatal life, when the production of and the demand for
Mg2+-bound metabolites is particularly high. There is growing evidence to suggest that Mg2+ depri-
vation is accompanied by different types of metabolic, immune, cardiovascular and neurological dis-
orders (de Baaij et al., 2015). However, mainly due to the lack of adequate mammalian genetic
models, it still remains unclear whether an imbalance in Mg2+ metabolism is merely associated with
or can directly trigger the latter pathophysiological processes. Furthermore, it has recently been
shown that cellular Mg2+ fluxes regulate the circadian rhythm and energy balance (Feeney et al.,
2016), CGRP-mediated osteogenic differentiation (Zhang et al., 2016) and synaptic plasticity (Pala-
cios-Prado et al., 2014), and that changes in the composition of brain interstitial Mg2+-
concentrations participate in the control of the sleep-wake cycle (Ding et al., 2016).
The remarkable recent progress in our understanding of the critical role of Mg2+ in health and
disease contrasts with the dearth of knowledge about the mechanisms governing cellular and organ-
ismal Mg2+ balance. Approximately 10 plasma membrane Mg2+ channels have been proposed
(Quamme, 2010) indicating a high degree of redundancy. However, quite some controversy sur-
rounds the biological role of many of these proteins, and the question whether there is a central
gatekeeper responsible for organismal Mg2+ balance has not yet been answered. The kinase-cou-
pled ion channel TRPM7 has been proposed as a ubiquitous, indispensable cellular Mg2+ entry path-
way (Schmitz et al., 2003; Chubanov et al., 2004; Ryazanova et al., 2010; Stritt et al., 2016).
However, studies with Trpm7 gene-deficient mice failed to confirm a corresponding in vivo role of
Trpm7. Thus, constitutive inactivation of Trpm7 in mice entailed early embryonic lethality for as yet
unknown reasons (Jin et al., 2008). Furthermore, tissue-specific deletions of Trpm7 in mouse
embryos affected morphogenesis of internal organs apparently in a Mg2+-independent manner
(Jin et al., 2008, 2012; Sah et al., 2013). More recently, it was suggested that the Mg2+ transporter
MagT1 rather than TRPM7 might play a critical role for Mg2+ homeostasis in T lymphocytes (Li et al.,
2011) and probably also in the whole embryo (Zhou and Clapham, 2009). Hence, the biological
role of TRPM7 requires further clarification.
In the present work, we focussed on the closest TRPM7 relative, TRPM6, because loss-of-function
mutations in TRPM6 cause hypomagnesemia (low Mg2+ blood levels) in human infants thought to
mainly result from renal Mg2+ wasting (Schlingmann et al., 2002; Walder et al., 2002; Voets et al.,
2004). However, deletion of Trpm6 in mice has resulted in neural tube closure defects and embry-
onic death (Walder et al., 2009) indicating a direct role of TRPM6 in developmental processes and
calling into question the simplistic view on the human TRPM6 phenotype.
By integrating systematic phenotyping of Trpm6 gene-modified mice with biochemical analysis,
gene expression, metabolomics, and cell biological approaches, we decipher the molecular and
organismal roles of TRPM6 in prenatal development and postnatal survival.
Results
TRPM6 function in extraembryonic cells is essential for fetal
development
To understand the role of Trpm6 in prenatal development, we determined the onset of embryonic
lethality in Trpm6 null embryos and investigated the expression pattern of Trpm6 at this stage. Using
a mouse strain carrying a gene-trap mutation in Trpm6 (Trpm6bgeo) (Table 1), we found that
Trpm6bgeo/bgeo embryos were present at embryonic days (e) 8.5–10.5 (Figure 1A). However, only
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a few mutants were found between e11.5–12.5 and no Trpm6bgeo/bgeo individuals were viable after
e14.5 (Figure 1A). Compared to e9.5 C-shaped Trpm6+/+ individuals, all Trpm6bgeo/bgeo embryos
isolated had not turned (S-shaped) and were smaller indicating a developmental retardation after
e8.5 (Figure 1B). Consequently, we investigated the expression pattern of Trpm6 in e8.5 fetuses by
in situ hybridization (ISH) and found that Trpm6 was specifically expressed in the visceral yolk sac
endoderm and extraembryonic chorion (Figure 1C) and that Trpm6 was not detectable in the neural
tube (Figure 1—figure supplement 1). Within the placental labyrinth a network of maternal sinus-
oids are intertwined with fetal blood capillaries, separated by two layers of transporting trophoblast
cells, syncytiotrophoblasts I (SynT-I) and II (SynT-II) (Simmons and Cross, 2005; Simmons et al.,
2008). At e8.5, morphogenesis of the labyrinth is in the initial stages and SynT-I/SynT-II cell layers
are distinguishable (Simmons and Cross, 2005; Simmons et al., 2008). We observed that Trpm6
expression was restricted to SynT-I cells (Figure 1D). In the fully maturated labyrinth at e14.5 Trpm6
mRNA was detected in syncytiotrophoblasts as well (Figure 1E).
Syncytiotrophoblasts and endoderm cells of the yolk sac exchange metabolites between the
maternal and fetal blood (Simmons and Cross, 2005). To clarify whether TRPM6 is required for
Mg2+ supply by extraembryonic tissues, we used inductively coupled plasma mass spectrometry
(ICP-MS) and found that relative magnesium (Mg2+) levels were reduced in the whole e9.5
Trpm6bgeo/bgeo embryos (Figure 1F). Thus, Trpm6 is specifically expressed in the placental labyrinth
and the yolk sac at the stage when the Mg2+ deficiency and growth delay of Trpm6-deficient
embryos become apparent.
To investigate whether TRPM6 activity in extraembryonic cells underlies the lethality of Trpm6
null embryos, we characterized a mouse strain with a ‘floxed’ (Trpm6fl) allele (Table 1). Cre-mediated
excision engendered viable mice heterozygous for the constitutive deletion mutation in Trpm6
(Trpm6D17/+). However, we were unable to produce live Trpm6bgeo/D17 or Trpm6D17/D17 offspring,
indicating that Trpm6D17 is a true null mutation (Table 1). The paternally inherited Sox2-Cre trans-
gene drives recombination only in epiblast cells, but not in extraembryonic tissues (Hayashi et al.,
eLife digest A balanced diet contains a variety of minerals such as magnesium ions, which are
required for many chemical reactions in our body. A shortage of magnesium ions is linked to many
diseases and is thought to be especially harmful to babies in the womb and shortly after birth.
Magnesium ion deficiency is widespread in human populations and in the US is thought to affect up
to 68% of people.
Despite its prominent role in human health, our understanding of how the body maintains the
right balance of magnesium ions remains extremely vague. Magnesium ions can enter and leave a
cell by passing through specific types of proteins that form channels in the membrane surrounding
the cell. There are thought to be around ten types of these magnesium ion channels in human cells,
but we do not know what roles any of them perform in the body. One such channel called TRPM6
may be particularly important because mutations in the gene that encodes this channel can cause
magnesium ion deficiency in human infants. However, the loss of TRPM6 in mice disrupts how
mouse embryos develop, suggesting that our current view on the role that TRPM6 plays in
regulating the magnesium ion balance in humans may be too simplistic.
To address this question, Chubanov et al. studied mice with mutations that disrupted the
production of TRPM6 in specific tissues only. The experiments show that TRPM6 primarily operates
in the placenta and intestine to regulate the balance of magnesium ions in the body. Further
experiments show that the loss of TRPM6 in adult mice leads to reduced lifespan, growth defects
and poor health by disrupting important biochemical reactions. Supplying the mutant mice with
magnesium ion supplements improved their health and could extend lifespans of normal animals.
The findings of Chubanov et al. demonstrate that TRPM6 plays a crucial role in regulating the
levels of magnesium ions in mice before birth and into adulthood. The next step is to carry out
large-scale experiments to investigate the effects of altering the levels of magnesium ions in human
diets.
DOI: 10.7554/eLife.20914.002
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2003). Notably, intercrosses of Trpm6D17/+;Sox2-Cre males and Trpm6fl/fl females resulted in viable
Trpm6D17/D17 pups at the expected ratio (Table 1). Therefore, the embryonic mortality of Trpm6-
deficient mice appears to be caused by the loss of TRPM6 in extraembryonic tissues.
Trpm6-deficient adult mice display shortened lifespan, growth defects
and Mg2+ deficiency
We next studied the impact of a global deletion of Trpm6 postnatally. Examination of Trpm6-defi-
cient (Trpm6D17/D17;Sox2-Cre) mice at weaning did not reveal conspicuous abnormalities. However,
during the follow-up period, we observed the gradual development of pathologies. Thus, Trpm6-
deficient mice had a lifespan of no longer than 16 weeks (Figure 2A). Mutants were growth-delayed,
and displayed a lighter fur colour and low night-time activity (Figure 2B,C). Weight gain and lean
body mass of Trpm6-deficient mice were reduced (Figure 2D,E), as was the muscle fibre area of the
gastrocnemius muscle of 12–13 week-old Trpm6-deficient mice indicative of sarcopenia (Figure 2F).
Mutant mice displayed kyphosis (Figure 2G) and completely lacked abdominal and subcutaneous fat
depots (Figure 2H,I) indicative of catabolic metabolism. However, the total amount of faeces (Fig-
ure 2—figure supplement 1A) and the calorimetrically determined faecal energy content, as a mea-
sure of energy excretion (Figure 2—figure supplement 1B), were not altered in Trpm6 mutants,
ruling out insufficient food intake. Histological analysis of internal organs (Figure 3) showed that
Trpm6-deficient mice developed lung emphysema and degeneration of lymphoid organs. Thus, the
thymus of mutant mice was rudimentary and the cortex region was not distinguishable. In the spleen
of Trpm6-deficient mice, the red pulp was substantially reduced. Hepatocytes of Trpm6-deficient
mice were depleted of glycogen granules (Figure 3), corroborating catabolic metabolism. It has
been suggested that low serum Mg2+ and TRPM6 function are associated with atherosclerosis in
humans (Maier, 2012; Tin et al., 2015). Therefore, we investigated whether such a phenotype would
develop in our mouse model as well. However, examination of thoracal aorta showed no signs of
atherosclerosis development in mutant mice (Figure 2—figure supplement 2).
Table 1. Postnatal survival of the mice with global and tissue-restricted deletions of Trpm6.
Targeted tissue Breeding strategy Expected F1 outcome* Survival of the mutant
Constitutive mutagenesis
Whole fetus ♂Trpm6bgeo/+ x ♀Trpm6bgeo/+ 25%Trpm6bgeo/bgeo
50% Trpm6bgeo/+
25% Trpm6+/+
no
Whole fetus ♂Trpm6D17/+ x ♀Trpm6 D17/+ 25% Trpm6 D17/D17
50% Trpm6 D17/+
25% Trpm6+/+
no
Whole fetus ♂Trpm6D17/+ x ♀Trpm6bgeo/+ 25% Trpm6bgeo/D17
25% Trpm6bgeo/+
25% Trpm6D17/+
25% Trpm6+/+
no
Conditional mutagenesis using Cre/LoxP system
Epiblast ♂Trpm6D17/+;Sox2-Cre x ♀Trpm6fl/fl 25% Trpm6D17/D17;Sox2-Cre
25% Trpm6D17/fl
25% Trpm6D17/+;Sox2-Cre
25% Trpm6fl/+
yes
Intestine ♂Trpm6D17/+;Villin1-Cre x ♀Trpm6fl/fl 25% Trpm6D17/fl;Villin1-Cre†
25% Trpm6D17/fl
25% Trpm6fl/+;Villin1-Cre
25% Trpm6fl/+
yes
Kidney ♂Trpm6D17/+;Ksp-Cre x ♀Trpm6fl/fl 25% Trpm6D17/fl;Ksp-Cre†
25% Trpm6D17/fl
25% Trpm6fl/+;Ksp-Cre
25% Trpm6fl/+
yes
*Genotypes were determined using genomic DNA extracted from tail fragments.
†Individuals were homozygous for Trpm6D17 allele in the targeted cells.
DOI: 10.7554/eLife.20914.005
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Figure 1. Assessment of Trpm6 function in extraembryonic tissues. (A) Survival of Trpm6bgeo/bgeo embryos obtained from Trpm6bgeo/+ intercrosses. (B)
Representative images of e9.5 Trpm6+/+ (+/+, n = 13) and Trpm6bgeo/bgeo (bgeo/bgeo, n = 5) embryos from dataset in (A). Dashed lines underline
C-shaped versus S-shaped morphology of Trpm6+/+ and Trpm6bgeo/bgeo embryos, respectively. (C) ISH on serial paraffin sections obtained from
wildtype n = 5 e8.5 fetus using antisense (left) and sense (right) probes for Trpm6. Boxes indicate the positions of the magnified images of the chorion
Figure 1 continued on next page
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Next, we asked whether the phenotype of Trpm6-deficient mice is caused by Mg2+ deficiency.
We employed ICP-MS to compare the concentrations of main elements in serum from controls and
Trpm6-deficient littermates. We found that, similar to humans with mutations in the TRPM6 gene
(Schlingmann et al., 2002; Walder et al., 2002), Trpm6-deficient mice developed hypomagnesemia
(Figure 2J). Serum Mg2+ levels of mutant mice were only 0.58 mM (36% of control value, 1.58 mM),
whereas concentrations of other elements were not changed (Figure 2J). A Mg2+-enriched diet is an
efficient way to alleviate hypomagnesemia in humans lacking TRPM6 (Schlingmann et al., 2002;
Walder et al., 2002). Therefore, we asked whether the phenotypes of Trpm6-deficient mice were
caused by Mg2+ deprivation and could be rescued by dietary supplementation. To this end, we
changed the regular chow (0.22% Mg2+) of 4 week-old mutant mice and control littermates for a
Mg2+ enriched diet (0.75% Mg2+). Notably, none of the Trpm6-deficient mice died during the follow-
ing 12 weeks of Mg2+ supplementation (Figure 2K). However, returning to regular chow resulted in
100% mortality of mutant mice within the following 13 weeks (Figure 2K). Mg2+ supplemented
mutants neither exhibited kyphosis nor lipodystrophy (data not shown). Furthermore, the morphol-
ogy of the lung, spleen, and thymus of Mg2+ supplemented mutants closely resembled that of con-
trol mice (Figure 3). We asked whether dietary Mg2+ supplementation of Trpm6bgeo/+ parents
would benefit the survival of Trpm6-deficient offspring. However, similar to a previous study
(Walder et al., 2009), we found that this treatment was inefficient.
Trpm6-deficient adult mice phenocopy salient pathologies reported for a set of mouse strains
advocated as genetic models of ‘accelerated’ or ‘premature’ aging (Kuro-o et al., 1997;
Trifunovic et al., 2004; Kujoth et al., 2005; Varela et al., 2005; Mostoslavsky et al., 2006;
Niedernhofer et al., 2006; van der Pluijm et al., 2007; Lo´pez-Otı´n et al., 2013). Similar to Trpm6-
deficient mice, the latter mutants display short lifespan, growth failure, low physical activity, kypho-
sis, lung emphysema, sarcopenia, lipodystrophy and degeneration of lymphoid organs. A character-
istic feature of these mouse strains is suppression of the somatotropic axis accompanied by
induction of xenobiotic detoxification gene networks in the liver (Niedernhofer et al., 2006; van de
Ven et al., 2006; van der Pluijm et al., 2007; Schumacher et al., 2008; Garinis et al., 2009;
Marin˜o et al., 2010), interpreted as a defensive organismal response, slowing down growth and
metabolism in favor of somatic preservation (Lo´pez-Otı´n et al., 2013). We asked whether Trpm6-
deficient mice would also display such protective metabolic responses. In fact, we found that serum
IGF1 concentrations were reduced in Trpm6-deficient mice as well (Figure 4A). Mutant mice had a
lower core body temperature (Figure 4B) and a profoundly reduced urinary content of major urinary
proteins (MUPs) (Figure 4C), two known features of supressed IGF1 signalling (Marin˜o et al., 2010;
Bartke et al., 2013). Even though mutant mice showed signs of overall energy shortage, circulating
levels of ketone bodies (ß-hydroxybutyrate) were not elevated (Figure 2—figure supplement 1C).
When subjected to an oral glucose tolerance test, mutant mice displayed lower peripheral glucose
concentrations than controls despite of a similar amount of insulin released, thus reflecting increased
insulin sensitivity (Figure 2—figure supplement 1D,E), another hallmark of suppressed IGF1 signal-
ling (Bartke et al., 2013). Notably, body weight and IGF1 serum levels were indistinguishable in
Mg2+ supplemented mutant and control mice suggesting that the variations observed in mice main-
tained on a regular diet were induced by Mg2+ deficiency (Figure 2—figure supplement 1F,G).
Figure 1 continued
(ch) and yolk sac (yc). Arrows indicate Trpm6-positive cells in the developing labyrinth (chorion) and the endoderm layer in the visceral yolk sac. (D) ISH
on serial paraffin sections of wildtype e8.5 placenta using DIG-labelled probes for Trpm6 (left), SynA (middle) and Gcm1 (right), respectively. Note:
Trpm6 expression was restricted to cells positive for SynA, a marker of SynT-I, and absent in cells expressing Gcm1, a marker of SynT-II. Representative
images of n = 2 independent tissues are shown. (E) ISH of WT e14.5 placenta with the antisense Trpm6 probe. The box indicates the position of the
magnified image. The Trpm6 signal is restricted to the labyrinth (lab) and not detectable in the decidua (dec) and trophoblast giant cells (GT).
Representative images of n = 8 independent placentas are shown. (F) Mg2+ levels in e9.5 Trpm6+/+ (n = 4) and Trpm6bgeo/bgeo (n = 3) embryos. Distal
segments of the embryos were used for genotyping, and the remaining parts were analysed by ICP-MS. Elementary magnesium (Mg) contents were
normalized to phosphorus (P) and sulfur (S) levels represented as mean±SEM. *-p0.05 (Student’s t-test).
DOI: 10.7554/eLife.20914.003
The following figure supplement is available for figure 1:
Figure supplement 1. ISH on serial paraffin sections obtained from wildtype e8.5 fetus using antisense (left) and sense (right) probes for Trpm6.
DOI: 10.7554/eLife.20914.004
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Figure 2. Pathophysiological changes displayed by Trpm6-deficient adult mice. Unless stated otherwise, 10–12 week-old Trpm6fl/+ (Control) and
Trpm6D17/D17;Sox2-Cre (KO) littermates were studied. (A–E) Mice were examined for survival rate (A), overall physical appearance (B), day/night activity
of 8 week-old individuals (C), growth rate (D) and lean mass (E). (F) Fibre size of the gastrocnemius muscle after hematoxylin-eosin staining. (G) X-ray
images of mice. The red arrow indicates the characteristic skeletal deformation (kyphosis) observed in Trpm6-deficient mice. (H) Assessment of
Figure 2 continued on next page
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Figure 2 continued
abdominal fat. Arrows indicate fat deposits observed only in control mice. (I) H and E staining of paraffin skin sections. Arrows indicate a layer of fat
cells present only in control mice. Histological analysis was performed with three animals per group resulting in similar observations. (J) The levels of
main elements in the serum of 8 week-old mice assessed by ICP-MS. (K) The survival rate of mice maintained on high Mg2+ (0.75%) and regular (0.22%)
chows. Data are represented as mean±SEM. ***-p0.001; **-p0.01; *-p0.05; n.s. – not significantly different (Student’s t-test); n – number of mice
examined.
DOI: 10.7554/eLife.20914.006
The following figure supplements are available for figure 2:
Figure supplement 1. Examination of energy balance in Trpm6-deficient mice.
DOI: 10.7554/eLife.20914.007
Figure supplement 2. Evaluation of atherosclerosis development in Trpm6-deficient mice.
DOI: 10.7554/eLife.20914.008
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Figure 3. Histology of internal organs of Trpm6-deficient mice. Hematoxylin-eosin staining of paraffin embedded tissue sections of 12–13 week-old
control (Control) and Trpm6-deficient (KO) mice maintained either on regular (0.22% Mg2+) or Mg2+ supplemented (0.75% Mg2+) chows. Trpm6-
deficient mice maintained on the regular diet showed marked airspace enlargement (indicated by stars) mimicking lung emphysema, distortion of
splenic red pulp (rp)/ white pulp (wp) microarchitecture, thymic atrophy, and reduction of intracellular glycogen in hepatocytes (indicated by arrows).
Histological analysis was performed with three animals per group resulting in similar observations.
DOI: 10.7554/eLife.20914.009
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Figure 4. Assessment of metabolic profiles of Trpm6-deficient mice. (A–C) 8 week-old Trpm6fl/+ (Control) and Trpm6D17/D17;Sox2-Cre (KO) littermates
were evaluated for (A) serum IGF1, (B) body temperature, (C) urinary MUPs content in individual mice. Data are represented as mean±SEM. ***-
p0.001; *-p0.05 (Student’s t-test); n – number of mice examined. (D) IPA analysis of genome-wide hepatic transcriptome profiling of Trpm6-deficient
(n = 3) vs control (n = 4) littermates. The diagram shows the top 5 of IPA Canonical Pathways significantly changed in mutant mice (Supplementary file
Figure 4 continued on next page
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Finally, we performed whole-genome profiling of the liver transcriptome (Supplementary file 1).
Applying a cut-off value of p0.1 for the false discovery rate (FDR), we identified 46 genes up- or
down-regulated in the livers of Trpm6-deficient mice (Figure 4—figure supplement 1,
Supplementary file 1). The majority of affected transcripts code for solute carrier transporters, cyto-
chrome P450 metabolising enzymes, glutathione S-transferases and proteins metabolizing steroids.
As expected, Ingenuity Pathway Analysis (IPA) revealed that the inactivation of Trpm6 is associated
with an induction of interconnected gene networks controlling toxicity responses and xenobiotic
metabolism governed by nuclear receptors such as retinoid X receptors (RXR), liver X receptor (LXR)
and farnesoid X receptor (FXR) (Figure 4D, Supplementary file 2). Hence, Trpm6-deficient mice
were characterized by suppression of the somatotropic axis and induction of xenobiotic detoxifica-
tion responses.
Trpm6-deficient mice display insufficient utilization of long-chain
acylcarnitines
To gain mechanistic insight into the altered energy metabolism of mutant mice, we quantified
serum, liver and skeletal muscle levels of 237 metabolites (Supplementary file 3, Figure 4—figure
supplement 2). Unexpectedly, alterations in Trpm6-deficient mice (FDR p0.1) were restricted to
only several metabolites representing mainly long-chain acylcarnitines (AC), phosphatidylcholines
(PC), and sphingomyelins (SM) (Figure 4E). These findings, as well as the results of gene array profil-
ing (Figure 4D) suggest that sustained Mg2+ deficiency triggers a specific metabolic response rather
than widespread unsystematic changes. In line with this idea, we noted that AC C18:1 and the
related AC C18 were consistently increased in tissues of Trpm6-deficient mice (Figure 4F–J),
whereas carnitine levels were not changed (Supplementary file 3). In conjunction with lowered con-
centrations of glucose and unchanged ketogenesis (Figure 2—figure supplement 1C), this constel-
lation is a metabolic ‘signature’ of a frequent inherited human disorder characterized by inefficient
b-oxidation of fatty acids due to mitochondrial carnitine palmitoyltransferase II deficiency
(Gempel et al., 2002; Bonnefont et al., 2004). AC C18:1 and C18 levels were normalized in serum
and tissues obtained from Mg2+ supplemented mutants (Figure 4F–J), implying that metabolic
changes of AC were caused by Mg2+ deficiency.
Consequently, we asked whether Mg2+ would specifically affect mitochondrial ATP production
(Figure 4K) and maintenance of the mitochondrial membrane potential (MMP) (Figure 4—figure
supplement 3A). To address this question, wildtype liver mitochondria were incubated in a buffer
containing 3 mM EDTA with or without 1–5 mM Mg2+. Such manipulations had no negative effect
on mitochondrial respiration when succinate was offered as an energy source (Figure 4K, Figure 4—
figure supplement 3A). In contrast, mitochondria failed to utilize octanoylcarnitine or palmitylcarni-
tine for ATP production (Figure 4K) and to maintain MMP (Figure 4—figure supplement 3A) in the
Figure 4 continued
2). Numbers of the commonly changed transcripts are indicated close to the lines connecting the pathways. (E) Venn diagram for sets of metabolites
significantly changed (FDR p0.05) in serum, liver and gastrocnemius muscle Trpm6-deficient (n = 6) vs control (n = 8) littermates (Supplementary file
3). Commonly changed metabolites are listed in different colours as outlined in the Venn diagram. (F–J) Levels of AC C18:1 (F–H) and AC C18 (I–J)
examined in the serum (F, I), liver (G) and gastrocnemius muscle (H, J) of Trpm6-deficient and control mice. Data are represented as mean±SEM. ***-
p0.001; **-p0.01; *-p0.05; n.s. – not significantly different to control group maintained on a regular Mg2+ diet (one-way ANOVA); n – number of
mice examined. (K) ATP production by mitochondria isolated from the liver of wildtype C57BL/6 mice with succinate, palmitoylcarnitine or
octanoylcarnitine as energy sources. ATP levels were determined after 30 min incubation of untreated (-) or treated (+) mitochondria by EDTA with or
without Mg2+. Data are represented as mean±SEM of 4–5 independent isolations (N). ##-p0.01; #-p0.05 significantly different to the control group;
***-p0.001; **-p0.01; *-p0.05 significantly different to the EDTA treated group (Student’s t-test). n.s. – not significantly different.
DOI: 10.7554/eLife.20914.010
The following figure supplements are available for figure 4:
Figure supplement 1. Gene expression profiling of Trpm6-deficient and control mice.
DOI: 10.7554/eLife.20914.011
Figure supplement 2. Metabolomic profiling of Trpm6-deficient and control mice.
DOI: 10.7554/eLife.20914.012
Figure supplement 3. Assessment of the membrane potential (Dym) in isolated mitochondria.
DOI: 10.7554/eLife.20914.013
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presence of EDTA. Importantly, ATP production and MMP could be fully rescued by the administra-
tion of 3–5 mM Mg2+ (Figure 4K, Figure 4—figure supplement 3A), but not Zn2+ or Ca2+ (Fig-
ure 4—figure supplement 3B). Thus, sustained Mg2+ deprivation impairs energy homeostasis
resulting in a catabolic metabolism in Trpm6-deficient mice, at least partially due to insufficient mito-
chondrial utilization of AC.
Trpm6 null mice develop Mg2+ deficiency due to a defect in intestinal
Mg2+ uptake
Next, we investigated the etiology of hypomagnesemia in Trpm6-deficient mice. ~50% of body
Mg2+ content is stored in bones, ~30% in muscle tissues and only ~1% in the serum (de Baaij et al.,
2015). Using ICP-MS we studied the Mg2+ content in bones (right tibia) and gastrocnemius muscle,
and observed that Mg2+ levels in bones of Trpm6 null mice were only 24% of control values
(Figure 5A). Furthermore, the Mg2+ content of muscle was also significantly reduced in Trpm6-defi-
cient mice (Figure 5B). Hence, Trpm6-deficient mice develop a severe systemic Mg2+ deficit.
It is generally assumed that the distal convoluted tubule (DCT) of the kidney is critical for whole-
body Mg2+ balance (de Baaij et al., 2015). Accordingly, immunostaining of control kidney cryosec-
tions with a TRPM6-specific antibody labelled nephron segments resembling DCT (Figure 5C).
TRPM6 was not detectable in the kidneys of Trpm6-deficient mice. Surprisingly, mutant mice exhib-
ited substantially reduced urinary Mg2+ excretion (only 14% of control values, Figure 5D), whereas
fecal Mg2+ loss was significantly increased (166%, Figure 5E), indicating that mice lacking TRPM6
develop Mg2+ deficiency primarily due to impaired intestinal Mg2+ uptake. Therefore, we studied
the expression pattern of Trpm6 in the intestine. Because the TRPM6-specific antibody did not effi-
ciently and specifically detect TRPM6 protein in the intestine, we resorted to ISH (Figure 5—figure
supplement 1). Trpm6 transcripts were not detectable in the small intestine, but Trpm6-specific sig-
nal was observed in absorptive epithelial cells of the colon (Figure 5—figure supplement 1). The
colon of mutant mice was not stained by a Trpm6-specific ISH probe (Figure 5F), consistent with the
notion that systemic Mg2+ deficit in Trpm6-deficient mice was primarily caused by a defect of Mg2+
uptake in the colon.
To directly assess the contribution of the kidney versus intestine to the Trpm6 null phenotype, we
employed Ksp-Cre (Shao et al., 2002) and Villin1-Cre (Madison et al., 2002) transgenic mice to spe-
cifically ablate floxed Trpm6 alleles in renal and intestinal epithelial cells, respectively (Table 1). Sur-
prisingly, conditional Trpm6 inactivation in the kidney neither impacted serum Mg2+ concentration
nor urinary Mg2+ excretion, and bone Mg2+ content was only slightly reduced (Figure 5G–J). In con-
trast, disruption of Trpm6 in the intestine resulted in hypomagnesemia, reduced bone Mg2+ content
and lowered urinary Mg2+ excretion (Figure 5K–N), indicating that wildtype kidneys are not able to
compensate for the ablation of intestinal TRPM6. Hence, in contrast to current thinking, our findings
support the new concept that Trpm6-dependent Mg2+ uptake in the intestine plays an indispensable
role for systemic Mg2+ balance.
TRPM6 cooperates with TRPM7 to regulate divalent cation currents
TRPM6 is invariably co-expressed with the TRPM7 channel and the question as to why TRPM6 func-
tion is non-redundant remains central to a mechanistic understanding of the Trpm6 null phenotype.
Because Trpm6 expression levels in the epithelial cells of the colon (Figure 5—figure supplement 1)
and the kidney (Figure 5C) are highly heterogeneous, we searched for an alternative native cell
model to dissect the functional interplay of TRPM6 and TRPM7. Trophoblast stem (TS) cells are
widely used to study the transport function of placental trophoblasts (Tanaka et al., 1998;
Simmons and Cross, 2005) and, as shown before (Figure 1), this cell type is crucial for the fetal
Trpm6 phenotype. Therefore, we derived Trpm6+/+ and Trpm6-deficient (Trpm6bgeo/bgeo) TS cells
from e3.5 blastocysts isolated from Trpm6bgeo/+ parents (Figure 6—figure supplement 1A). We
also produced Trpm7+/+ and Trpm7-deficient (Trpm7D17/D17) TS cells (Figure 6—figure supplement
2A) using Trpm7D17/+ mice (Jin et al., 2008). As expected, RT-PCR analysis revealed that wildtype
TS cells expressed TRPM6 and TRPM7 (Figure 6—figure supplement 1B, Figure 6—figure supple-
ment 2B). Trpm6bgeo/bgeo TS cells were maintained in culture for >40 passages. Furthermore, analy-
sis of DNA content showed that the proportion of polyploidy was similar in Trpm6+/+ and
Trpm6bgeo/bgeo TS cells (Figure 6—figure supplement 1C,D), suggesting that inactivation of Trpm6
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Figure 5. Examining of Mg2+ balance in Trpm6-deficient adult mice. (A–F) Assessment of 8 week-old Trpm6fl/+ (Control) and Trpm6D17/D17;Sox2-Cre
(KO) littermate males. (A) Mg2+ levels in bones and (B) gastrocnemius muscle assessed by ICP-MS. (C) Immunostaining of kidney cryosections using a
TRPM6-specific antibody. Representative images are shown (n = 2 tissues per genotype). The blue square indicates the position of the confocal and
differential interference contrast magnified images acquired from control tissue. Arrows indicate labelling of the apical surface of renal tubules. (D) 24 hr
Figure 5 continued on next page
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did not affect the self-renewal of Trpm6bgeo/bgeo stem cells. In contrast, Trpm7D17/D17 TS cells did
not proliferate, unless the cell culture medium was supplemented with additional Mg2+ (Figure 6—
figure supplement 2C), supporting the concept that TRPM7 plays a pivotal role in cellular Mg2+
uptake that cannot be maintained by TRPM6 alone (Schmitz et al., 2003; Chubanov et al., 2004;
Ryazanova et al., 2010).
TRPM6 and TRPM7 have been suggested as molecular correlates of MgATP- and Mg2+-regulated
cation currents responsible for the cellular uptake of divalent cations including Mg2+ (Aarts et al.,
2003; Nadler et al., 2001; Schmitz et al., 2003; Chubanov et al., 2004; Voets et al., 2004;
Zhang et al., 2014). Patch-clamp analysis showed that Trpm6bgeo/bgeo TS cells display substantially
reduced TRPM6/M7-like outward currents at +80 mV (Figure 6A). Due to permeation block by
extracellular divalent cations (Nadler et al., 2001; Fleig and Chubanov, 2014), inward currents at
physiological membrane potentials were very small (Figure 6A; p0.001, t-test). However, exposure
of TS cells to a divalent cation free (DVF) solution resulted in large monovalent cation currents
(Figure 6B). Under these conditions, mutant TS cells exhibited a comparable reduction of inward
(p0.01, t-test) as well as outward (p0.05, t-test) monovalent currents (Figure 6B).
Cytosolic levels of free Mg2+ ([Mg2+]i) and MgATP ([MgATP]i) have been suggested to exert a
negative feedback mechanism on TRPM6/M7 channel activity (Fleig and Chubanov, 2014). We
observed (Figure 6C) that currents in Trpm6bgeo/bgeo TS cells were more susceptible to concentra-
tion-dependent inhibition by cytosolic MgATP (p0.0001, F-test). The calculated IC50 value for
Trpm6+/+ was 3.17 mM (Hill (h) slope =  1.81). Currents in Trpm6bgeo/bgeo cells were inhibited by
[MgATP]i with an IC50 value of 1.45 mM (h =  1.95; p0.0015, F-test). These results suggest that
physiological concentrations of [MgATP]i varying between 2–7 mM in mammalian cells (Gu¨n-
ther, 2006; Romani, 2011) will affect currents in Trpm6+/+ and Trpm6bgeo/bgeo cells differently. In
contrast, we observed no significant differences in [Mg2+]i concentration-response curves for
Trpm6+/+ and Trpm6bgeo/bgeo currents (p=0.62, F-test) (Figure 6D). The obtained IC50 value for
Trpm6+/+ currents was 0.60 mM (h =  1.14) and was not significantly altered in Trpm6bgeo/bgeo TS
cells (0.72 mM, h =  1.18; p=0.22, F-test), suggesting that physiological concentrations (0.3–1 mM,
(Gu¨nther, 2006; Romani, 2011)) of [Mg2+]i will exert similar effects on ion currents in Trpm6
+/+ and
Trpm6bgeo/bgeo cells.
Next, we asked whether TRPM6 channel activity would be detectable in the absence of TRPM7.
Remarkably, we observed that Trpm7D17/D17 TS cells completely lacked TRPM6/M7-like currents
(Figure 6E,F). These findings cogently support our model (Chubanov et al., 2004) that native
TRPM6 primarily functions in close cooperation with TRPM7. TRPM6 facilitates Mg2+ uptake by
increasing the amplitude of TRPM7-like currents and relieving TRPM7 from the negative feedback
by MgATP (Figure 6G).
Finally, we studied whether Mg2+ deprivation may affect energy metabolism at the cellular level.
We chose the genetically tractable human haploid leukaemia cell line (HAP1 cells)
(Essletzbichler et al., 2014; Blomen et al., 2015; Wang et al., 2015) as a new model system.
CRISPR/Cas9-mediated ablation of the TRPM7 protein in HAP1 cells (Figure 6—figure supplement
3A,B) completely abolished TRPM7-like currents (Figure 6—figure supplement 3C). When cultured
in standard medium for 24 hr, TRPM7-deficient cells were characterized by a reduced total cellular
Mg2+ content and a Mg2+-dependent proliferation defect (Figure 6—figure supplement 3D,E). In
Figure 5 continued
urinary and (E) fecal Mg2+ excretion rates. (F) ISH on paraffin sections obtained from the colon of control and Trpm6-deficient mice (n = 2 tissues per
genotype). (G–J) Examination of 6 month-old Trpm6fl/+ (Control) and Trpm6D17/fl;Ksp-Cre (Kidney KO) littermate males. (G) Immunostaining of TRPM6 in
kidney cryosections. Arrows indicate labelling of renal tubules. (H–I) Determination of Mg2+ in serum (H) and bones (I). (J) 24 hr urinary Mg2+ excretion
rate. (K–N) Assessment of 6 month-old Trpm6fl/+ (Control) and Trpm6D17/fl;Villin1-Cre (Intestine KO) littermate males. (K) ISH on paraffin sections of the
colon using a Trpm6-specific probe (n = 2 tissues per genotype). (L, M) Mg2+ levels in the serum (L) and bones (M). (N) 24 hr urinary Mg2+ excretion
rate. Data are represented as mean±SEM. ***-p0.001; **-p0.01; *-p0.05; n.s. – not significantly different (Student’s t-test); n – number of mice
examined. Histological analysis in (F) and (K) was performed with n = 3 animals per group resulting in similar observations.
DOI: 10.7554/eLife.20914.014
The following figure supplement is available for figure 5:
Figure supplement 1. Expression pattern of Trpm6 in the intestine.
DOI: 10.7554/eLife.20914.015
Chubanov et al. eLife 2016;5:e20914. DOI: 10.7554/eLife.20914 13 of 32
Research article Biophysics and Structural Biology Human Biology and Medicine
AE
Δ17/Δ17
+/+ 
F
D
TRPM6
TRPM7
TRPM7
TRPM7
Mg2+
Mg2+
MgATP
G
***
B 
C 
Figure 6. Characterization of TRPM6/M7-like currents in Trpm6- and Trpm7-deficient TS cells. (A) Left panel: Whole-cell currents measured at  80 mV
and +80 mV over time in Trpm6+/+ (n = 22) and Trpm6bgeo/bgeo (n = 22) TS cells. Middle panel: Representative current-voltage relationships obtained at
12 s and 400 s. Right panel: Bar graphs of current amplitudes at +80 mV (400 s). (B) Measurements were performed in control (n = 16) and Trpm6-
deficient (n = 14) TS cells analogous to (A) except that the external saline (containing 2 mM Mg2+ and 1 mM Ca2+) was exchanged with divalent-free
Figure 6 continued on next page
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addition, TRPM7-deficient HAP1 cells had reduced intracellular ATP levels (Figure 6—figure supple-
ment 3F). Finally, the respiration rate of TRPM7-deficient HAP1 cells was significantly lower when
compared to control cells (Figure 6—figure supplement 3G,H).
Assessment of dietary Mg2+ fortification on the lifespan of wildtype
mice
Our studies with Trpm6-deficient mice clearly demonstrated that a sustained disruption of Mg2+
homeostasis is detrimental for overall health and eventually reduces the lifespan of affected animals.
Conversely, we asked whether a Mg2+-enriched diet might exert a beneficial effect on the lifespan
of wildtype mice. Since there are no prior reports on lifespan extension of mice subjected to life-
long dietary Mg2+ supplementation (or any other mineral), we performed proof-of-principle experi-
ments to investigate, if such an effect can be observed. To this end, we used only the long-lived
B6C3F1 hybrid mouse strain to avoid genotype-specific effects on disease susceptibility observed in
longevity experiments with inbred strains (Lipman et al., 1999; Turturro et al., 1999;
Mitchell et al., 2016). At this stage, we studied only females because of a larger number of early
losses of males due to fighting (Miller et al., 2007). Finally, we studied animals only under patho-
gen-free conditions, since Mg2+ may elicit a protective effect via the immune system
(Brandao et al., 2013; Chaigne-Delalande et al., 2013). Consistent with published reports
(Turturro et al., 1999), the mean lifespan of B6C3F1 mice (886 days regarded as 100%) was signifi-
cantly extended (1100 days, 125%) by dietary restriction (DR) (Figure 7A,B, Table 2). Remarkably,
supplementation with three Mg2+ salts (Mg(CH3COO)2, Mg(OH)2 and MgCl2) increased the mean
lifespan of mice by approximately 10% (976, 976 and 961 days, respectively). The nutritional CaCl2
administration was without any significant effect (828 days). In contrast to DR, animals supplemented
with Mg2+ had a normal or even increased body weight (Figure 7C), ruling out the possibility that
high dietary Mg2+ affected the lifespan of mice due to reduced food intake. Hence, opposite to
Trpm6-dependent Mg2+ deprivation, dietary Mg2+ supplementation may have a beneficial effect on
the lifespan of mice suggestive future large-scale longevity studies with varied conditions and
species.
Discussion
Here, we present a new mechanistic model of the regulation of Mg2+ homeostasis during develop-
ment and postnatal life of mice. Against current thinking we show in vivo that TRPM6 is not required
for embryonic development per se, but primarily operates in placenta and intestine to regulate
Mg2+ levels by transcellular transport, while TRPM6 function in the kidney – commonly thought to
be essential – is expendable for organismal Mg2+ balance. We demonstrate that ablation of TRPM6
in adult mice leads to reduced lifespan, growth defects and profoundly impaired health of mutant
mice due to defective energy metabolism. We also show that dietary Mg2+ supplementation is not
only sufficient to prevent all Trpm6 null pathologies, but Mg2+ is the only mineral known so far able
to extend the lifespan of wildtype mice.
Figure 6 continued
(DVF) solution (black bar). Right panel shows currents measured before (filled bars) and after application of DVF solution (open bars) at 400 s and 600 s,
respectively. (C, D) Dose-dependent inhibition of currents (+80 mV, 400 s) by [MgATP]i and [Mg
2+]i, respectively (n = 4–18 cells per concentration). (E, F)
Whole-cell currents of Trpm7+/+ (n = 15) and Trpm7D17/D17 (n = 10) TS cells studied similar to (A, B). Data are represented as mean±SEM. ***-p0.001;
**-p0.01; *-p0.05; n.s. – not significantly different (Student’s t-test). n – number of cells examined. (G) A suggested model for the molecular role of
TRPM6 in epithelial cells.
DOI: 10.7554/eLife.20914.016
The following figure supplements are available for figure 6:
Figure supplement 1. Characterization of Trpm6-deficient TS cells.
DOI: 10.7554/eLife.20914.017
Figure supplement 2. Examination of TS cells deficient in Trpm7.
DOI: 10.7554/eLife.20914.018
Figure supplement 3. Evaluation of human haploid leukaemia (HAP1) cells deficient in TRPM7.
DOI: 10.7554/eLife.20914.019
Chubanov et al. eLife 2016;5:e20914. DOI: 10.7554/eLife.20914 15 of 32
Research article Biophysics and Structural Biology Human Biology and Medicine
***
n.s.
*
n.s.
n.s. n.s.
25
30
35
40
45
 t
h
gi
e
w 
y
d
o
B
(g
)
1 year old mice
***
*** * * *** n.s.
25
30
35
40
45
50
B
o
d
y
 w
e
ig
h
t 
(g
)
2 years old mice
C
***
* *
*
***
n.s.
800
900
1000
1100)
s
y
a
d( 
e
g
a l
a
vi
vr
u
s 
n
a
e
M
A B
###
#### # n.s.
0
25
50
75
100
300 500 700 900 1100 1300
S
u
rv
iv
a
l 
(%
)
Age (days)
Control
MgAc
MgCl2
Mg(OH)2
DR
Figure 7. Effects of whole-life Mg2+ dietary treatments on B6C3F1 mouse strain. (A) Mean survival ages of B6C3F1 mice maintained at a control diet
(Control, n = 335), under dietary restriction (DR, n = 60), or supplemented by Mg(CH3COO)2 (MgAc, n = 15), Mg(OH)2 (n = 15), MgCl2 (n = 15) and
CaCl2 (n = 15) in drinking water as outlined in Table 2. Pooled Mg shows results for all Mg
2+ supplemented mice pooled within a common group
(n = 45). The obtained survival distributions were analysed by the MATLAB computing environment to calculate mean lifespans and corresponding
P-values: ***-p0.001; **-p0.01; *-p0.05; n.s. – not significantly different. Alternatively, survival data of control mice versus individually treated groups
were assessed by log-rank test: ###-p0.001; ##-p0.01; #-p0.05; n.s. – not significantly different. (B) Kaplan-Meier survival distributions of B6C3F1 mice
maintained on control diet (Control), Mg2+ supplemented groups (MgAc, MgCl2, Mg(OH)2) or mice under dietary restriction (DR). (C) Body weights
(mean+/-SEM) of control and nutritionally fortified mice studied in (A). ***-p0.001; **-p0.01; *-p0.05; n.s. – not significantly different (one-way
ANOVA). n – number of mice examined.
DOI: 10.7554/eLife.20914.020
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It has been reported that constitutive Trpm6 inactivation leads to embryonic lethality, resulting in
the generally accepted tenet that Trpm6 is required for the development of the embryo proper
(Walder et al., 2009). On the contrary, we provide genetic evidence that the embryonic mortality of
Trpm6-deficient mice is caused by the loss of TRPM6 activity in placental SynT-I and yolk sac endo-
derm cells, and that Trpm6-deficient embryos are depleted of Mg2+. Altogether, we postulate that
Trpm6 controls the maternal Mg2+ supply to the fetus, and that growth failure and death are sec-
ondary phenotypes induced by Mg2+ deprivation. Differences in the role of TRPM6 for embryonic
survival of humans and mice may be attributable to different morphologies of the placental
exchange interfaces, fetal growth rate, litter size and dietary preferences (Simmons and Cross,
2005). However, at present we cannot exclude that loss-of-function mutations in TRPM6 might be
associated with prenatal mortality in humans as well. Pioneering positional cloning studies
(Schlingmann et al., 2002; Walder et al., 2002) and follow-up case reports (Schlingmann et al.,
2005; Konrad and Schlingmann, 2014) focused on hospitalized human infants selected by the crite-
rion of deleterious Mg2+ deficiency. Hence, additional TRPM6 phenotypes, such as infertility or
embryonic death, might have been overlooked. Accordingly, it has recently been shown that single
nucleotide polymorphisms in human TRPM6 are associated with a neural tube closure defect, i.e.
meningomyelocele (Sarac¸ et al., 2016). Of note, dietary Mg2+ supplementation is common practice
of pregnant women (Durlach et al., 2004). Our work provides first mechanistic insight as to how this
essential mineral is delivered to the fetus.
There is growing evidence to suggest that Mg2+ deprivation is involved in the development of
metabolic, immune, cardiovascular and neurological disorders (de Baaij et al., 2015). However, due
to the lack of adequate mammalian genetic models, it is still unclear whether impaired Mg2+ homeo-
stasis can be regarded as the cause or the consequence of the latter pathophysiological processes.
Therefore, we studied the impact of TRPM6 deletion on postnatal mice. Trpm6-deficient mice dis-
played shorter lifespans, failure to thrive, low physical activity, kyphosis, lung emphysema, sarcope-
nia and degeneration of lymphoid organs. In addition, Trpm6-deficient animals developed signs of
catabolic metabolism such as lipodystrophy, increased insulin sensitivity and hypothermia, and
showed suppression of the somatotropic axis accompanied by induction of xenobiotic detoxification
gene networks in the liver. Altogether, we noted that the complex phenotype of Trpm6-deficient
mice mirrors many phenotypic hallmarks of mutant mouse strains that are generally considered
genetic models of ‘accelerated aging’ in the scientific literature (Lo´pez-Otı´n et al., 2013). Further-
more, our unbiased screen for metabolic pathways dysregulated in Trpm6-deficient mice revealed
an error in energy metabolism reminiscent of humans with mutations in the gene coding for mito-
chondrial carnitine palmitoyltransferase II, the most common inherited disorder of lipid metabolism
in adult humans (Bonnefont et al., 2004; Gempel et al., 2002). Interestingly, an early biochemical
study revealed that Mg2+ and MgATP could regulate activity of mitochondrial carnitine acyltransfer-
ase activity (Saggerson, 1982). Accordingly, in proof-of-concept experiments, we demonstrated
that Mg2+ is specifically required for the utilization of acyl carnitines (AC) as an energy source in liver
mitochondria. Hence, these results suggest that insufficient mitochondrial utilization of AC repre-
sents a plausible mechanism contributing to the pathologies developed by Trpm6-deficient mice.
The exact role of Mg2+ in AC metabolism as well as the molecular pathophysiology of carnitine
Table 2. Dietary regimes used to maintain B6C3F1 mice.
Experimental group Chow 5 K54 Drinking water (ad libitum) Number of mice
Control ad libitum Regular water* 335
Dietary restriction 60% of ad libitum Regular water 60
Magnesium acetate supplemented ad libitum 1 g/l Mg(CH3COO)2.(H2O)4 in regular water 15
Magnesium chloride supplemented ad libitum 1 g/l MgCl2 in regular water 15
Magnesium hydroxide supplemented ad libitum 14 mg/l Mg(OH)2 in regular water
† 15
Calcium chloride supplemented ad libitum 0.8 g/l CaCl2 in regular water 15
*Regular water contained 0.44 mg/l Mg2+.
†Mg(OH)2 concentration was lowered to prevent overall alkalization of the diet.
DOI: 10.7554/eLife.20914.021
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palmitoyltransferase II deficiency is still not completely understood and, being beyond of the scope
of the current manuscript, has to be addressed in future studies.
Notably, if Trpm6-deficient mice were fed with a high Mg2+ diet, they were viable and displayed
normal physical activity, morphology of internal organs and tissue levels of AC, indicating that the
phenotypes in Trpm6-deficient mice were triggered by Mg2+ deficiency. Therefore, we studied in
more detail how mutant mice develop organismal Mg2+ deprivation. According to current thinking,
the active transport of Mg2+ in the kidney, in particular in DCT, determines the final urinary Mg2+
concentration and is central to whole-body Mg2+ balance (de Baaij et al., 2015). Contrary to this
model, we demonstrate that global inactivation of Trpm6 leads to Mg2+ deficiency due to a defect
in intestinal Mg2+ uptake. To interrogate the renal role of TRPM6, we conditionally inactivated
Trpm6 in the kidney and, surprisingly, did not observe any changes in serum Mg2+ levels. In contrast,
intestine-specific disruption of Trpm6 resulted in hypomagnesemia indicating that wildtype kidneys
were not able to counterbalance the ablation of TRPM6 in the intestine. Taken together, our findings
lend strong support to the new concept that Trpm6-dependent Mg2+ uptake by the colon plays an
indispensable role for systemic Mg2+ balance in mice. However, we assume that renal TRPM6 activity
may have an important role under conditions of insufficient dietary Mg2+ intake, for instance, during
prolonged fasting periods.
Currently there are two suggested mechanistic models of hypomagnesemia in humans carrying
mutations in TRPM6. A pioneering study of patients with congenital hypomagnesemia anticipated
that Mg2+ malabsorption in the intestine plays a key role in organismal Mg2+ deprivation
(Friedman et al., 1967; Milla et al., 1979). More recently, it was reported that in affected humans
renal Mg2+ loss plays a key role (Schlingmann et al., 2002; Walder et al., 2002). The results
obtained with Trpm6-deficient mice are well compatible with the former model. However, we cannot
exclude physiological differences between humans and mice, an important issue to address in future
studies. In conclusion, our findings support the idea that TRPM6 is a central gatekeeper of organis-
mal Mg2+ balance in mammals and that this role cannot be compensated for by any other Mg2+
channel and transporter.
What is the molecular mechanism underlying insufficient Mg2+ intake in Trpm6-deficient mice?
TRPM6 and its close homolog TRPM7 have been invoked as molecular correlates of cation currents
responsible for Mg2+ entry into cells. In order to circumvent the limitations and pitfalls imposed by
overexpression of recombinant proteins, we employed TS cells to compare the roles of native
TRPM6 and TRPM7. We found that stem cells express both TRPM6 and TRPM7, thus mimicking the
in vivo situation. Inactivation of Trpm6 did not affect the self-renewal of TS cells. In contrast, Trpm7-
deficient cells were not able to proliferate unless the cell culture medium was supplemented with
additional Mg2+, supporting the idea that TRPM7 plays a non-redundant role in cellular Mg2+ uptake
(Schmitz et al., 2003; Chubanov et al., 2004; Ryazanova et al., 2010). We further showed that
wildtype TS cells exhibited [Mg2+]i- and [MgATP]i-sensitive divalent cation currents, and that inactiva-
tion of Trpm6 reduced current amplitudes. In contrast, deletion of TRPM7 caused complete ablation
of these currents. Remarkably, ion currents in Trpm6 deficient TS cells still expressing TRPM7 were
substantially more sensitive to intracellular MgATP when compared to TRPM6/M7 co-expressing
cells. Thus, in a native environment the presence of TRPM6 reduces the sensitivity of TRPM6/M7-like
currents to inhibition by intracellular MgATP. It has recently been reported that the TRPM6/M7 het-
eromer is completely insensitive to MgATP after heterologous expression in HEK 293 cells
(Zhang et al., 2014). Thus, native TRPM6/M7 currents do not fully recapitulate the latter findings
obtained in a heterologous expression system and further studies are required to clarify these dis-
crepancies. Nevertheless, our results are concordant with our model (Chubanov et al., 2004) that
native TRPM6 functions primarily as a subunit of heteromeric TRPM6/M7 complexes by increasing
current amplitudes and relieving TRPM7 from inhibition by [MgATP]i (Figure 6G). Such facilitated
Mg2+ entry is most probably not required for any cell autonomous function, but is necessary for epi-
thelial Mg2+ transport and the maintenance of serum Mg2+ levels.
Inadequate nutritional Mg2+ intake is commonplace in Western societies (in up to 68% of the US
population [King et al., 2005]). In addition, a growing percentage of the population is exposed to
drug-induced forms of hypomagnesemia (de Baaij et al., 2015). Consequently, we asked whether
wildtype mice would benefit from extra Mg2+ supplementation. Our proof-of-concept experiments
suggest that life-long Mg2+ supplementation may extend the lifespan of mice. This idea is concor-
dant with the recent observation that Mg2+acting alone or in conjunction with dietary calorie
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restriction counteracts lifespan-shortening effects of RNA-DNA hybrid (R loop) accumulation in
yeasts and human HeLa cells (Abraham et al., 2016). Hence, large-scale investigations of nutritional
Mg2+ adjustments and their impact on health- and lifespan of different species should be enlighten-
ing in this regard.
Materials and methods
Mouse strains
Experiments involving animals were done in accordance with the EU Animal Welfare Act and were
approved by the local councils on animal care (permit No 55.2-1-54-2532-134-13 from
the Government of Oberbayern, Germany, and permit No 2347-15-2014 from the State Ministry of
Brandenburg, Germany).
Trpm6 gene-trap mutant mouse strain
A mouse line carrying a gene-trap mutation in Trpm6 (129S5/SvEvBrd-C57BL/6) (Woudenberg-
Vrenken et al., 2011) was obtained from the Texas Institute for Genomic Medicine (stock No.
TG0020; RRID:IMSR_TAC:tf0834). In the mutant allele (Trpm6bgeo), exons 2 and 3 of Trpm6 were
replaced by a bgeo reporter sequence (bgeo). The bgeo cassette includes a splice acceptor site
sequence (SP), a bacterial b-galactosidase marker (LacZ), an internal ribosome entry site (IRES) and a
neomycin resistance sequence (NeoR). Consequently, the Trpm6bneo allele drives the expression of
an aberrant transcript encoding only exon 1 of Trpm6 spliced to bgeo. In order to obtain the
Trpm6bgeo allele in a C57BL/6J genetic background, Trpm6bgeo/+ 129S5/SvEvBrd-C57BL/6 mice
were backcrossed with C57BL/6J mice for six generations. Mice were genotyped using PCR analysis
of genomic DNA isolated from tail fragments. DNA was extracted and purified using the GenElute
mammalian genomic DNA isolation kit (Sigma-Aldrich). DNA samples were examined by PCR using
a set of allele-specific oligonucleotides (Metabion) and REDTaq DNA polymerase (Sigma-Aldrich).
Trpm6bgeo allele was analyzed using primers Trpm6bgeo-Forward 5’-GCGTTGGCTACCCGTGAT-3’
and Trpm6bgeo-Reverse 5’-CTGATAAGGAAGGCTGCTCTAAG-3’ with PCR settings: 94˚C 3’, 94˚C
30’’, 55˚C 30’’, 72˚C 1’, 40 cycles, 72˚C 5’. The amplified PCR product (367 bp) was visualised by
standard agarose gel electrophoresis and confirmed by sequencing.
Mice with a conditional Trpm6 (Trpm6fl) allele
A mouse line (C57BL/6) carrying a conditional mutation in Trpm6 was generated by Taconic Artemis
(Ko¨ln, Germany). Mouse genomic fragments corresponding to the targeted Trpm6 segment were
obtained from the C57BL/6J RPCIB-731 BAC library. The mutant locus contained two intronic LoxP
sites flanking exon 17 of Trpm6. In addition, the targeting construct contained thymidine kinase (TK)
and neomycin resistance (NeoR) markers allowing for negative and positive selection of mutant ES
clones. NeoR was flanked by additional FRT recombination sites allowing for the subsequent dele-
tion of NeoR sequences using Flp recombinase. BAC fragments, recombination sites, NeoR and TK
were assembled in the targeting vector using an ET-cloning approach. The final targeting construct
was confirmed by sequencing. C57BL/6N Tac embryonic stem (ES) cells were grown on mitotically
inactive mouse embryonic fibroblasts (MEF) in DMEM (high glucose) containing 20% FBS (PAN) and
1200 mg/mL leukemia inhibitory factor (Millipore). The authentication of ES cells was performed by
Taconic Artemis and no further authentication was performed by the authors. 107ES cells were elec-
troporated (Biorad Gene Pulser) with 30 mg linearized targeting vector. G418 (200 mg/mL) selection
was started on day 2 and counter-selection with gancyclovir (2 mM) was started on day 5 after elec-
troporation. ES clones obtained were examined for homologous recombination and single integra-
tion by Southern blotting (SB) using two probes located in 3’ and 5’ arms of the targeting construct
and one additional probe located in NeoR. Sequences of the targeting vector, probes and SB
images are available upon request. Mutant ES cells (clone 3339-AG-1) were injected into blastocysts
isolated from uteri of 3.5 days post coitum (dpc) BALB/c females. The injected blastocysts were
transferred to uteri of 2.5 dpc pseudopregnant females. Chimerism of the offspring obtained (G0)
was evaluated by coat colour contribution (white/black). Highly chimeric G0 males were crossed with
C57BL/6 females carrying a ubiquitously expressed Flp transgene to delete the NeoR cassette from
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the mutant locus. Germline transmission in G1 offspring was identified by the presence of black coat
colour followed by PCR analysis of genomic DNA isolated from tail fragments.
Deletion of exon 17 using Cre recombinase results in a frame-shift in the Trpm6 transcript. The
efficiency of Cre-mediated deletion of the floxed exon 17 (referred to as Trpm6D17 allele) was exam-
ined using females ubiquitously expressing the Sox2-Cre transgene. The maternally inherited Sox2-
Cre transgene allows for efficient recombination of LoxP-flanked genomic sequences in the single-
cell embryo (Hayashi et al., 2003). This approach was employed to produce Trpm6D17/+ individuals
(Table 1). Mice were genotyped using PCR analysis of genomic DNA isolated from the tail fragments
as described above for Trpm6bgeo/+ mice. Trpm6+ allele was analyzed using primers Trpm6+-For-
ward 5’-AGAGACGTGCAGTGTAGGACAGAG-3’ and Trpm6+-Reverse 5’-ACGGCACACAGAAAA-
CACCAG-3’ with PCR settings: 94˚C 3’, 94˚C 30’’, 64˚C 30’’, 72˚C 1’, 40 cycles, 72˚C 5’ (PCR
product 549 bp). Trpm6fl allele was studied using primers Trpm6fl-Forward 5’-GCAAATACAAGCAA-
CACCTCC-3’ and Trpm6fl-Reverse 5’-GAAGTTCCTATTCCGAAGTTCC-3’ with PCR settings: 94˚C 3’,
94˚C 30’’, 53˚C 30’’, 72˚C 1’, 40 cycles, 72˚C 5’ (PCR product 368 bp). Trpm6D17 mutation was deter-
mined using primers Trpm6D17-Forward 5’-TGTCTTCCATGTTGCTACGA-3’ and Trpm6D17-Reverse
5’-CTTCCGGTCCACAGTTCAT-3’ with PCR settings: 94˚C 3’, 94˚C 30’’, 53˚C 30’’, 72˚C 1’, 40 cycles,
72˚C 5’ (PCR product 362 bp). Amplified PCR products were confirmed by sequencing.
Mice with organ-restricted inactivation of Trpm6
Transgenic mice expressing Cre recombinase under the control of the mouse Sox2 promoter (Sox2-
Cre mice, C57BL/6J; RRID:IMSR_HAR:3359) (Hayashi et al., 2003), Kidney-specific/Cadherin16 pro-
moter (Ksp-Cre mice, C57BL/6J; RRID:MGI:4452131) (Shao et al., 2002) and Villin1 promoter (Vil-
lin1-Cre mice, C57BL/6J; RRID:MGI:3581405) (Madison et al., 2002) were obtained from the
Jackson Laboratory (Sacramento, CA, USA, stock No. 008454, 012237, and 004586 respectively). To
conditionally inactivate Trpm6, Sox2-Cre, Ksp-Cre and Villin1-Cre mice were crossed with
Trpm6D17/+ mice to produce Trpm6D17/+;Sox2-Cre, Trpm6D17/+;Ksp-Cre, and Trpm6D17/+;Villin1-Cre
males. Next, these males were bred with Trpm6fl/fl females to generate offspring with a global, kid-
ney and intestine-restricted disruption of Trpm6 as outlined in Table 1. Inheritance of Sox2-Cre,
Ksp-Cre and Villin1-Cre transgenes was determined by PCR analysis of tail DNA at conditions
described previously (Madison et al., 2002; Shao et al., 2002; Hayashi et al., 2003).
Trpm7D17/+ mice
A mouse line carrying a conditional mutation in Trpm7 (Trpm7fl/flmice, 129 S6/SvEvTac; RRID:IMSR_
JAX:018784) was kindly provided by David Clapham, Harvard Medical School, Boston, USA. The
mutant locus contains two intronic LoxP sites flanking exon 17 of the Trpm7 gene. Deletion of exon
17 results in a frame-shift mutation (Trpm7D17 allele) and subsequent disruption of TRPM7. To pro-
duce Trpm7D17/+ mice, Trpm7fl/fl females were crossed with Sox2-Cre males and the resulting off-
spring were genotyped by PCR as described previously (Jin et al., 2008). The generated Trpm7D17/+
strain was maintained by intercross of Trpm7D17/+ parents.
Housing, metabolic and behaviour profiling of mice
Housing conditions
Mice were kept in individually ventilated polycarbonate cages (IVC System, Tecniplast, Germany).
Cages were changed weekly and were on a 12 hr light/dark cycle with artificial lighting. Temperature
and relative humidity were 22 ± 1˚C and 50 ± 5%, respectively. Breeding animals were maintained
on a multigrain chow Ssniff M-Z (Ssniff GmbH, Germany) and drinking water containing 20.1 mg/l
Mg2+ and 81.9 mg/l Ca2+ (ad libitum). Litters were weaned at three weeks of age, genotyped and
desired littermates were housed in cages as described above except that a ‘maintenance’ chow Sniff
R/M-H (Ssniff GmbH, Germany) was used. Both Ssniff M-Z and Ssniff R/M-H chows contained 0.22%
Mg2+ and 1.0% Ca2+. In dietary Mg2+ supplementation experiments, 4 week-old Trpm6-deficient
and control mice were fed Ssniff R/M-H chow containing 0.75% Mg2+ (Ssniff GmbH, Germany).
Collection of specimen
Mice were weighed, killed and blood samples were collected by a cardiac puncture technique. Blood
samples were incubated 30 min at RT, clots were removed by centrifugation (Heraeus Pico 17, 3500
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rpm for 30 min at RT) and the resulting serum samples were stored at  80˚C. Internal organs were
removed, flash frozen in liquid nitrogen and stored at  80˚C. Right tibias were dissected, cleaned
from muscle tissues, dried overnight at 70˚C and kept at RT. To determine urinary and fecal excre-
tion rates of main minerals, mice were maintained for 24 hr in individual metabolic cages (Acme
Metal Products, USA) under housing conditions as described above and supplied ad libitum with
drinking water and chow. After 24 hr, the urine and feces produced were collected. Urine samples
were stored at  80˚C. Feces specimen were dried overnight at 70˚C and stored at  20˚C.
Determination of Mg2+ levels and other main elements
Content of main elements in bones, serum, urine, feces and gastrocnemius muscle samples was
determined by inductively coupled plasma mass spectrometry (ICP-MS) by ALS Scandinavia (Swe-
den) as reported previously (Rodushkin and Odman, 2001; Rodushkin et al., 2004).
Monitoring of food and water intake, locomotor activity, body lean mass,
body temperature and energy content
Food and water intake were recorded with an automated Drinking and Feeding Monitor system
(TSE Systems, Germany) with food baskets connected to weight sensors. An adaptation period of 2
days was followed by 3 days of data collection. Cumulative food intake and locomotor activity
(based on infrared beams, InfraMot-Activity System, TSE Systems, Germany) were recorded. The
core body temperature was measured using a rectal probe as reported previously (Braun et al.,
2009). In vivo analysis of body lean mass was performed in conscious, restrained mice by nuclear
magnetic resonance (EchoMRITM-100H; EchoMRI LLC, USA) weekly and before metabolic measure-
ments. The energy content in feces was determined by bomb calorimetry (IKA C5003; IKA Werke,
Staufen, Germany).
Evaluation of atherosclerosis development
Assessment of atherosclerosis lesions was performed as described previously (van der Vorst et al.,
2015).
Determination of insulin growth factor 1 (IGF1), major urinary proteins
(MUPs), ß-hydroxybutyrate and glucose-tolerance test
Serum concentrations of IGF1 were analysed by a Mouse/Rat IGF-I ELISA kit (R and D-Systems).
MUPs content as assessed by SDS-PAGE gel electrophoresis of 1 ml urine samples from individual
mice. ß-Hydroxybutyrate was measured by a commercially available assay kit (Sigma-Aldrich). For a
glucose-tolerance test, mice were fasted for 6 hr, followed by an oral gavage of glucose (2 mg/g
body weight). Blood samples were collected via the tail vein and blood glucose levels were mea-
sured using a contour glucometer (Bayer, Germany). Plasma levels of insulin were measured using a
commercially available ELISA kit (Alpco).
Histological examination of tissues
Hematoxylin-eosin staining of tissue sections
Tissues were fixed overnight at 4˚C in 4% paraformaldehyde (PFA), dehydrated through a series of
ethanol washes, cleared in three changes of xylene and embedded in paraffin. Tissue sections (5 mm)
were cut by RM2125 RTS microtome (Leica Microsystems, Germany), mounted on Superfrost Plus
slides (Menzel-Gla¨ser), and dried at 70˚C for 1 hr. Tissue sections were dewaxed in xylene, rehy-
drated through a series of ethanol washes to deionized water. Slides were incubated in Mayers
hematoxylin solution (Carl Roth) for 10 min at RT followed by incubation in 0.5% Eosin Y solution
(Carl Roth) for 13 min at RT. The colour reaction was stopped by deionized water, slides were dehy-
drated in ethanol, cleared in xylene and mounted using mounting medium (Carl Roth). Slides were
examined using an Olympus CX41 microscope and Cell Imaging software (Olympus, Germany).
Immunohistochemistry (IHC)
Polyclonal TRPM6-specific antibodies were raised by immunization of rabbits with H2N-CERDK
NRSSLEDHTRL-COOH peptide coupled via the N-terminus to keyhole limpet hemocyanin (KLH) and
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purified by peptide affinity chromatography (Eurogentec, Belgium). Whole kidneys were dissected
from eight week-old mice and embedded in Jung tissue freezing medium (Leica Microsystems, Ger-
many). 10 mm cryosections were produced by a CM 3050S cryotom (Leica Microsystems, Germany),
mounted on Superfrost Plus slides (Menzel-Gla¨ser), air-dried for 20 min and fixed in 2% (w/v) para-
formaldehyde in PBS (pH 7.4) for 20 min at RT. After washing in PBS (210 min), sections were
blocked with 5% goat serum/0.5% Triton X100 (Sigma-Aldrich) in PBS for 2 hr at RT. The rabbit anti-
TRPM6 antibody (1 mg/ml in 5% goat serum/0.5% Triton X100/PBS) was applied overnight at 4˚C.
Afterwards sections were washed in PBS (310 min, RT) and a goat anti-rabbit antibody conjugated
with Alexa 488 (Life Technologies, Darmstadt, Germany; 1 mg/ml in 5% goat serum/PBS) was applied
for 1 hr at RT. After washing in PBS (310 min, RT), sections were embedded in Dako Mounting
Fluid (Dako Cytomation). Differential interference contrast and confocal images were obtained with
a confocal laser scanning microscope LSM 540 META (Carl Zeiss, Germany). We used a Plan-Apo-
chromat x63/1.4 oil objective, the 488 nm excitation wavelength of an argon laser, and a 505–570
nm band-pass filter. Acquired DIC and confocal images were analysed using the LSM 540 META
software (Carl Zeiss, Germany).
In situ hybridization (ISH)
cDNA templates for the production of cRNA Trpm6 probes were produced by PCR with the follow-
ing 2 sets of primers: Probe-1-Forward: 5’-aattaaccctcactaaagggGAGAGGAGGCCACAGTCAAG-3’;
Probe-1-Reverse: 5’-taatacgactcactatagggGCTCAAAGACGATGTCACGA-3’; Probe-2-Forward: 5’-
aattaaccctcactaaagggCCTGTCAAAGAAGAAGAGGAA-3’; Probe-2-Reverse: 5’-taatacgactcactatagg-
gAGAAAAGACTTCACAATG-3’. Primers contained T7 (reverse primer lower case) or T3 (forward
primer lower case) RNA polymerase sites. PCR products were gel purified (Qiagen Gel Extraction
Kit) and sequence verified (ARGF). Digoxigenin (DIG) labelled cRNA probes were synthesized
according the manufacturer’s instructions (Roche, 10x DIG RNA labelling kit). Both probe sets pro-
duced similar results on n = 5 placentas at each gestational time point examined, and n = 3 WT kid-
ney or intestinal samples. Gcm1 and SynA riboprobes were described previously (Dawson et al.,
2012). Preparation of tissue sections and ISH procedures were performed as previously described
(Dawson et al., 2012). Slides were imaged by an Aperio slide scanner and analysed using Image-
Scope software.
Whole-genome profiling of the liver transcriptome in Trpm6-deficient
mice
Microarray data were deposited in NCBI Gene Expression Omnibus (GEO) (GSE70457). Liver tissues
were collected from 12–13 week-old Trpm6-deficient (Trpm6D17/D17;Sox2-Cre, n = 3) and control
(Trpm6+/fl, n = 4) male littermates, snap-frozen in liquid nitrogen and stored at  80˚C. Total RNA
was extracted using the GenElute mammalian total RNA purification kit (Sigma-Aldrich). Whole
genome profiling was performed using a GeneChip Mouse Gene 1.0 ST Array (Affymetrix) at Source
Bioscience (Berlin, Germany). Biotinylated single-stranded DNA was prepared according to the stan-
dard Affymetrix protocol (Whole Transcript Expression arrays) from 100 ng total RNA using the WT
terminal labelling kit. 2.5 mg of fragmented and labelled ssDNA were hybridized for 16–18 hr at
45˚C. GeneChips were washed and stained in an Affymetrix Fluidics Station 450. GeneChips were
scanned using the Affymetrix GeneChip Scanner 3000. Processing of the array data, including quality
assessment, background correction, normalization and summarization was performed with the Affy-
metrix Expression Console (version 1.4.0). All statistical analyses were carried out with the statistical
computing environment R (version 3.1.2, www.R-project.org). Differential expression analysis was
performed with the R package limma (version 3.22.4) (Ritchie et al., 2015). p-values were adjusted
for multiple testing with the Benjamini-Hochberg method for controlling the false discovery rate
(FDR). A heatmap was generated for a group of 46 transcripts differentially expressed at a level of
FDR p0.1. Analysis of the affected pathways and causal transcriptional regulators was performed
by Ingenuity pathway analysis (IPA) environment (www.ingenuity.com, RRID:SCR_008653) using a set
of 2443 transcripts changed at p0.05 confidence level (t-test).
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Metabolomic profiling of serum, liver and skeletal muscle in Trpm6-
deficient mice
Serum, liver and gastrocnemius muscle samples were collected from 8–10 week-old control (Trpm6+/
fl, n = 8) and Trpm6-deficient (Trpm6D17/D17;Sox2-Cre, n = 6) male littermates, flash frozen in liquid
nitrogen and stored at  80˚C. Metabolomic analyses were performed at Biocrates Life Sciences AG
(Innsbruck, Austria). Measurements comprised the quantification of 237 metabolites including 41
amino acids/biogenic amines, 40 acylcarnitines (AC), 22 bile acids (BA), 14 lysophosphatidylcholines
(LysPC), 77 phosphatidylcholines (PC), 15 sphingomyelins (SM), 17 eicosanoids/prostaglandins and
11 energy metabolism intermediates as outlined in Supplementary file 3. To extract metabolites,
tissue samples were treated with corresponding extraction buffers and incubated in a chilled ultra-
sonic bath for 5 min. Afterwards samples were centrifuged and the supernatant was used for analy-
sis. FIA- and LC-MS/MS measurement techniques were applied as described in detail previously
(Pena et al., 2014). All statistical analyses have been applied by using the statistical computing envi-
ronment R (www.r-project.org). Metabolite measurements containing more than 75% missing values
or more than 75% of values below the limit of detection (LOD) across all samples per matrix were
removed from analysis. Measured concentrations of metabolites were log2-transformed for moder-
ated statistical tests. Measurements were scaled to m = 0 mean and unit standard deviation for each
biological matrix separately for heatmap visualization. Changes in average metabolite levels
between control and mutant individuals were tested using a linear model framework implemented in
the R package Limma (Smyth, 2004). Resulting P-values for moderated t-test were corrected for
multiple testing by Benjamini and Hochberg approach. A p-value threshold of 0.05 was considered
as significant. A Heatmap diagram for metabolites with significant changes was calculated with the
R-package Heatmap using ward clustering and Euclidean distance measure and the R-package Ven-
nDiagram was applied to calculate a Venn diagram of significantly changed metabolites across sam-
ple matrices.
Mitochondrial isolations and analyses
Mouse liver mitochondria were isolated by differential centrifugation from freshly prepared homoge-
nates as previously described (Springer et al., 2002; Schulz et al., 2015). Liver mitochondria were
further purified by Percoll density gradient centrifugation (Schulz et al., 2013). Isolated mitochon-
dria were subjected to quantification by the Bradford assay and kept on ice until use. Assessment of
the mitochondrial membrane potential Dym (MMP) was followed by Rh123 fluorescence quenching
(Ex. 485 nm, Em. 528 nm) in a 96-well plate reader (BioTek) and quantitatively evaluated by curve
analysis as previously described (Schulz et al., 2013) (set threshold slopes were 0.67 for start
points and 0.67 for end points, respectively). In order to exclude fluctuations at measurement start,
slope calculations were started after 6 min measurement time with slope values  1.5. A kit-based
assay (ATP Bioluminescence Assay Kit, Roche) was used to analyze the ATP content from cleared
lysates after 30 min mitochondrial ATP synthesis at RT, initiated by the addition of 160 mM ADP and
stopped at 95˚C for 5 min. For both analyses assay buffer composition was 0.2 M sucrose, 10 mM
MOPS-Tris, 1 mM Pi and 10 mM EGTA. Respiratory substrates were either succinate (25 mM)/rote-
none (2 mM), or DL-octanoylcarnitine (10 mM)/malate (12.5 mM), or DL-palmitoylcarnitine (10 mM)/
malate (12.5 mM). Buffers and solutions were essentially Mg2+-free, as determined by ICP-OES
(Ciros Vision, SPECTRO Analytical Instruments GmbH) after wet ashing with 65% nitric acid
(Zischka et al., 2011). EDTA, Mg2+, Ca2+, or Zn2+ was added at the concentrations indicated in the
respective figures.
Isolation and characterization of mouse trophoblast stem (TS) cells
Isolation of TS cells
TS cells were isolated as described (Tanaka et al., 1998), with several modifications
(Erlebacher et al., 2004; Natale et al., 2009). 3.5 days post-coitum blastocysts were isolated from
Trpm6bgeo/+ parents. Individual blastocysts were incubated in a humidified cell culture incubator
(Heraeus, Thermo Fisher Scientific) at 37% and 5% CO2 for 3 days in 12 well plates (Sarstedt) con-
taining 8104/well irradiated mouse embryonic fibroblasts (MEFs) (Millipore) in RPMI 1640 medium
(Life Technologies) supplemented with 20% fetal bovine serum (ES type, Life Technologies), 1 mM
sodium pyruvate (cell culture type, Sigma-Aldrich), 100 mM b-mercaptoethanol (Sigma-Aldrich), 50
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mg/ml streptomycin and 50 U/ml penicillin (all from Life Technologies), 1.0 mg/ml heparin (cell culture
type, Sigma-Aldrich), 25 ng/ml human recombinant FGF4 (R and D systems), 5 ng/ml human recom-
binant TGF-b1 (R and D systems), 10 ng/ml recombinant activin A (R and D systems) and an addi-
tional 10 mM MgCl2. The attached embryos were disaggregated by 0.05% trypsin-EDTA (Life
Technologies) and derived cells were further co-cultured with MEFs as described above. The
obtained TS cells were propagated and adapted to MEF-free conditions without additional Mg2+ in
the culture medium. The authentication of TS cells was based on expression of a trophoblast stem
cell marker Esrrb, characteristic morphological appearance and ability to proliferate only in the pres-
ence of FGF4 and TGF-b1 (Tanaka et al., 1998; Simmons and Cross, 2005). TS cells were tested
negative for mycoplasma contamination using QuickTest kit (Biotool).
Genotypes of TS cells were determined by PCR analysis of genomic DNA using conditions
described above for Trpm6bgeo/+ mice. TS cells were further examined by RT-PCR. Total RNA was
extracted from TS cell pellets using the GenElute mammalian total RNA purification kit (Sigma-
Aldrich). First strand cDNA synthesis was performed by RevertAid H minus reverse transcriptase
(Thermo Scientific). PCR was performed using REDTaq DNA polymerase (Sigma-Aldrich) with two
primer sets: Trpm6a-Forward 5’-GCTGCCAAATCTGCCACAAT-3’ and Trpm6a-Reverse 5’-TGCCCA-
CAGTCCCATCATCACA-3’ or Trpm6b-Forward 5’-CCAGCTCAAAAGACCCTCACAGATGC-3’ and
Trpm6b-Reverse 5’-CACACCACATCTTTTCCGACCAG-3’. The following PCR conditions were used:
94˚C 3’, 94˚C 30’’, 56˚C 30’’, 72˚C 1’, 35 cycles, 72˚C 5’. Amplified PCR products were 651 bp or
586 bp, respectively. Self-renewal of Trpm6bgeo/bgeo TS cells was assessed by determination of DNA
content as described previously (Tanaka et al., 1998). Briefly, TS cells were cultured for 3 days, dis-
sociated by trypsin-EDTA and fixed with 40% ice-cold ethanol. Fixed TS cells were incubated in pro-
pidium iodide (PI) staining solution (50 mg/ml PI, 0.2 mg/ml RNaseA in PBS, all from Sigma-Aldrich)
for 30 min at RT. Stained cells were dissolved in PBS and examined using BD FACSCalibur (BD Bio-
sciences, Germany) and FlowJo software (www.flowjo.com).
Trpm7-deficient and corresponding control TS cells were derived as described above using
Trpm7D17/+ mice. The obtained Trpm7+/+ and Trpm7D17/D17 TS cells were propagated and adapted
to MEF-free conditions in cell culture medium supplemented with 10 mM MgCl2. Genotypes of TS
cells were determined by PCR analysis of genomic DNA using conditions described for Trpm7D17/+
mice. The lack of Trpm7 transcripts in Trpm7D17/D17 TS cells was verified by RT-PCR using primers
Trpm7-Forward 5’-AGTAATTCAACCTGCCTCAA-3’ and Trpm7-Reverse 5’-ATGGGTATCTCTTCTG
TTATGTT-3’ and the following PCR conditions: 94˚C 3’, 94˚C 30’’, 50˚C 30’’, 72˚C 1’, 35 cycles, 72˚C
5’. The amplified PCR product was 287 bp.
To study growth rates, TS cells of each genotype were seeded in 6-well plates (1105 cells/well)
in cell culture medium containing 10 mM MgCl2. After 24 hr (day 1), the culture medium was
replaced with fresh medium either with or without 10 mM MgCl2 and the cells were further cultured
for additional 3 days. The cell density was determined at 24 hr intervals using a Neubauer chamber
(Marienfeld Superior). To calculate growth rates, the cell number at day 1 was designated as 100%.
The experiment was repeated three times and a Student’s t-test was applied to compare the growth
rates of control versus mutant cells.
Electrophysiology
Whole-cell currents were measured using an EPC10 patch-clamp amplifier and PatchMaster software
(Harvard Bioscience, Germany). Voltages were corrected for a liquid junction potential of 10 mV.
Currents were elicited by a ramp protocol from  100 mV to +100 mV over 50 ms acquired at 0.5 Hz
and a holding potential of 0 mV. Inward and outward current amplitudes were extracted at  80 mV
and +80 mV and were normalized to cell size as pA/pF. Capacitance was measured using the auto-
mated capacitance cancellation function of EPC10. Patch pipettes were made of borosilicate glass
(Science Products) and had resistances of 2–3.5 MW. The standard extracellular solution contained
(in mM): 140 NaCl, 3 CaCl2, 2.8 KCl, 10 HEPES, and 11 glucose (all from Sigma-Aldrich). A divalent-
free (DVF) extracellular solution contained (in mM): 140 NaCl, 2.8 KCl, 10 HEPES, 11 glucose and 5
EDTA. TRPM6/M7-like currents were induced by Mg2+-free intracellular solution, containing (in mM):
140 Cs-glutamate, 8 NaCl, 10 EGTA, 5 EDTA and 10 HEPES. All solutions were adjusted to pH 7.2
using a FE20 pH-meter (Mettler Toledo, Germany). The osmolality of all solutions was adjusted to
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290 mOsm using Vapro 5520 osmometer (Wescor Inc., USA). Data were compared by an unpaired
Student’s t-test.
For Mg2+ ([Mg2+]i) and MgATP ([MgATP]i) dose responses, the intracellular pipette solution con-
tained (in mM): 120 Cs-glutamate, 8 NaCl, 10 HEPES, 2.7 EDTA and various amounts of MgCl2 or
MgATP (Sigma-Aldrich). The solutions were adjusted to pH 7.2 and 290 mOsm. Concentrations of
MgATP and free Mg2+ were calculated using WebMaxC (maxchelator.stanford.edu). To determine
IC50 values, datasets were fitted using a nonlinear (least-squares) regression analysis (GraphPad
Prism 6.0 software) and the following equation:
EðcÞ ¼EminþðEmax EminÞ=ð1þ 10
^ððIC50 CÞhÞÞ
with E being the effect/current at a given concentration C of inhibitor, Emin the minimal effect/cur-
rent, Emax the maximally achievable effect, IC50 the half-maximal concentration and h the Hill slope
factor. Statistical analysis of dose-response curves and IC50 values was performed using the extra
sum-of-squares F test with the threshold P value 0.05 (GraphPad Prism 6.0).
Characterization of TRPM7-deficient human haploid leukaemia (HAP1)
cells
Isolation and maintenance of TRPM7-deficient HAP1 cells
Wildtype parental cells (clone C631) and TRPM7-deficient (clone 10940–04) HAP1 cells were
acquired from Horizon Genomics (Vienna, Austria). The authentication of HAP1 cells was performed
by Horizon Genomics (Essletzbichler et al., 2014) and no further authentication was performed by
the authors. A CRISPR/Cas9 approach was used to introduce a 17 bp (GTGACCATTTTAATCAG)
deletion in exon 4 of the human TRPM7 gene resulting in a frame-shift mutation. Genotypes of
HAP1 cells were confirmed by PCR amplification of genomic DNA using primers hTRPM7-Forward
5’-TATTTGTATGCACCTTTGTA-3’ and hTRPM7-Reverse 5’-TGTTTTAATCTCACCTTTTT-3’ with PCR
parameters: 94˚C 3’, 94˚C 30’’, 50˚C 30’’, 72˚C 1’, 40 cycles, 72˚C 5’. PCR products (364 bp and 347
bp in wild type and mutant clones, respectively) were confirmed by sequencing. HAP1 cells were
tested negative for mycoplasma contamination using QuickTest kit (Biotool).
HAP1 cells were cultured in Iscove’s Modified Dulbecco’s Medium (IMDM) supplemented with
10% FBS and 100 U/ml penicillin, 100 mg/ml streptomycin and 10 mM MgCl2 (all from Thermo Fisher
Scientific). Cells were maintained in a humidified cell culture incubator (Heraeus, Thermo Fisher Sci-
entific) at 37˚C and 5% CO2. Western blot analysis was performed as described previously
(No¨renberg et al., 2016). Examinations of growth rates and endogenous TRPM7-like currents were
conducted as described above for TS cells.
Determination of total Mg2+ content
HAP1 cells of each genotype were grown in T175 cm2 flasks (Sarstedt) in 10 mM MgCl2 supple-
mented cell culture medium as described above. At ~50% confluence the medium was replaced with
fresh medium without 10 mM MgCl2 and the cells were cultured for additional 24 hr. Next, cells
were washed with PBS, disaggregated by trypsinization and collected in 50 ml plastic tubes (Sar-
stedt). After centrifugation (3 min, 1000 rpm), the cell pellet was resuspended in 1 ml PBS and
passed to a fresh 1.5 ml tube. The cell suspension was centrifuged (3 min, 3500 rpm), supernatant
was completely removed and the cell pellet was dried overnight at 70˚C. The dried cell pellet was
analysed by ICP-MS in ALS Scandinavia (Sweden). The experiment was repeated four times.
Assessment of ATP levels
HAP1 cells of each genotype were seeded in 96-well plates (white wall/clear bottom, type 3610,
Costar) at a density of 5105 cells/well in the 10 mM MgCl2 supplemented cell culture medium (100
ml/well); eight wells per genotype were used. After 24 hr, the cell culture medium was replaced with
fresh regular medium (without additional 10 mM Mg2+) and the cells were cultured for additional 24
hr. To determine cell viability, 10 ml of CCK-8 reagent (Cell Counting Kit-8) was added in four wells
per genotype. The plates were incubated for 3 hr in the cell culture incubator (Heraeus, Thermo
Fisher Scientific) at 37˚C and 5% CO2. Next, 96-well plates were incubated at room temperature (RT)
for 30 min and 100 ml of CellTiter-Glo2.0 reagent (Promega) was added to the remaining four wells
per genotype. After 10 min incubation at RT, either ATP-induced luminescence or CCK-8
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absorbance (450 nm) were determined using a plate reader (FLUOstar Omega, BMG Labtech). CCK-
8 absorbance was used to normalize ATP-induced bioluminescence. The normalized biolumines-
cence of wildtype cells was designated 100%. The experiment was repeated six times.
High-resolution respirometry of living HAP1 cells
Oxygen consumption of HAP1 cells was assessed by Oxygraph-2k measurements (Oroboros Instru-
ments GmbH, Austria) as described previously (Pesta and Gnaiger, 2012). Briefly, WT and KO
HAP1 cells were maintained in standard medium supplemented by 10 mM MgCl2. The Mg
2+ supple-
mented medium was replaced with regular medium (without additional 10 mM Mg2+) and the cells
were cultivated for a further 24 hr. Next, oxygen flux from routine respiration of 1.5106 cells at
37˚C and maximal oxygen flux after stepwise CCCP addition (2 ml steps from 1 mM stock solution)
were determined. The oxygen flux was baseline-corrected for non-mitochondrial oxygen consuming
processes by the addition of 0.5 mM rotenone (complex I inhibitor, Sigma-Aldrich) and 2.5 mM anti-
mycin A (complex III inhibitor, Sigma-Aldrich).
Whole-life dietary treatments of B6C3F1 mice
Mice were raised in a specific pathogen-free facility at Jackson Laboratory Sacramento (Sacramento,
CA, USA). The long-lived B6C3F1 hybrid strain (Lipman et al., 1999; Turturro et al., 1999) was
used. Specifically, F1 females were derived by crossing C57BL/6J females with C3H/HeJ males. The
produced B6C3F1 females were weaned at 3 weeks of age, and afterwards kept in individually venti-
lated polycarbonate cages (Thoren Caging Systems) on multigrain chow 5 K54 (Purina) containing
0.22% Mg2+ and drinking water containing 0.44 mg/l Mg2+. Five mice were housed per cage and
cages were changed every two weeks. The housing rooms were with artificial lighting and 12 hr
light/dark cycle (6 am to 6 pm). Temperature and relative humidity in animal rooms were 22 ± 4˚C
and 50 ± 15%, respectively. At 5 months of age, mice were assigned to control, dietary restricted
(DR) or supplemented cohorts as outlined in Table 2. For supplementation experiments, correspond-
ing salts (Sigma-Aldrich) were diluted in drinking water that was administered ad libitum throughout
the lifespan of all groups (Table 2). To reduce bias, the supplemented and control groups were
examined simultaneously and the study was performed as a blinded trial. Mice were inspected daily.
Necropsies of randomly selected dead mice revealed that 58 of 88 control females (66%) developed
tumours. 8 of 11 females (73%) from the three Mg2+ supplemented groups also had tumours sug-
gesting that high dietary Mg2+ had no substantial effect on tumor rate at death. Kaplan-Meier sur-
vival distributions were computed to illustrate survival times. For statistical analysis, we used
MATLAB computing environment and programming language (MathWorks, www.de.mathworks.
com), in particular its built-in fast convolution function that allows to find the distribution of the sum
of independent random variables, given the distributions of individual variables. To enable statistical
comparisons between control and dosed groups, the distribution of the mean lifespan of 15 control
mice was found as a convolution of the original distribution of lifespans of all control mice. To calcu-
late P-values of the mean lifespan from the dosed groups relative to the control group, we calcu-
lated the probability of the average of 15 control mice showing the same or more extreme (away
from control mean) lifespan than the experimentally determined mean lifespan of the dosed mice. A
similar technique was used to find P-values for pooled Mg and dietary restriction groups relative to
controls. The MATLAB code is available from the Dryad Digital Repository (Chubanov and Guder-
mann, 2016). In addition, the survival data of control mice versus individual treated groups were
assessed by log-rank test using GraphPad Prism software. P-values for both approaches are indi-
cated in Figure 7A.
Acknowledgements
We thank Jackson Laboratory Sacramento for the help with whole-life dietary treatments of mice.
We thank David Clapham for providing Trpm7fl/fl mice; Ilia Rodushkin for the support in ICP-MS;
Marc Freichel and Petra Weißgerber for their help to isolate TS cells; Fabian Bamberg and Mike
Notohamiprodjo for the help with X-ray imaging of mice; Sabine Schmitt for the help with high-reso-
lution respirometry. We thank Renate Heilmair and Joanna Zaißerer for technical assistance. VC, SZ
and TG were supported by the Deutsche Forschungsgemeinschaft, TRR 152. WJ and AS were sup-
ported by the German Federal Ministry of Education and Research (BMBF, DZD). SZ was supported
Chubanov et al. eLife 2016;5:e20914. DOI: 10.7554/eLife.20914 26 of 32
Research article Biophysics and Structural Biology Human Biology and Medicine
by Marie-Curie Fellowship (REA) FP7-PEOPLE-2012-CIG. EPCV and WC were supported by the
Deutsche Forschungsgemeinschaft (SFB1123-A1) and German Centre for Cardiovascular Research
(MHA VD1.2).
Additional information
Funding
Funder Grant reference number Author
Deutsche Forschungsge-
meinschaft
TRR 152-P15 Vladimir Chubanov
Thomas Gudermann
Deutsche Forschungsge-
meinschaft
SFB1123-A1 Emiel PC van der Vorst
Christian Weber
Deutsche Forschungsge-
meinschaft
TRP 152-P14 Susanna Zierler
Seventh Framework Pro-
gramme
Marie-Curie Fellowship FP7-
PEOPLE-2012-CIG
Susanna Zierler
The funders had no role in study design, data collection and interpretation, or the decision to
submit the work for publication.
Author contributions
VC, TG, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or
revising the article, Contributed unpublished essential data or reagents; SF, AW, CL, CE, WJ, HB,
AB, BA, LM, LS, EPCvdV, Acquisition of data; DGS, AGR, Conception and design, Acquisition of
data, Analysis and interpretation of data, Drafting or revising the article; YS, Acquisition of data;
Analysis and interpretation of data; FT, VJ, CW, Analysis and interpretation of data; O¨AY, KS, Acqui-
sition of data, Analysis and interpretation of data; AS, HZ, Conception and design, Acquisition of
data, Analysis and interpretation of data; SZ, Acquisition of data, Analysis and interpretation of data,
Drafting or revising the article
Author ORCIDs
Vladimir Chubanov, http://orcid.org/0000-0002-6042-4193
David G Simmons, http://orcid.org/0000-0002-4115-9371
Susanna Zierler, http://orcid.org/0000-0002-4684-0385
Ethics
Animal experimentation: Experiments involving animals were done in accordance with the EU Animal
Welfare Act and were approved by the local councils on animal care (permit No 55.2-1-54-2532-134-
13 from Government of Oberbayern, Germany, and permit No 2347-15-2014 from State Ministry of
Brandenburg, Germany).
Additional files
Supplementary files
. Supplementary file 1. Whole genome profiling of hepatic transcripts altered in Trpm6-deficient
mice. Dataset is available in the Dryad Digital Repository (Chubanov and Gudermann, 2016). (1)
Genome-wide analysis of hepatic transcriptome in control vs Trpm6-deficient mice. (2) Up- and
down-regulated transcripts in the liver of Trpm6-deficient mice with the false discovery rate (FDR)
p0.1.
DOI: 10.7554/eLife.20914.022
. Supplementary file 2. Ingenuity Pathway Analysis (IPA) analysis of hepatic transcripts altered in
Trpm6-deficient mice. Dataset is available from the Dryad Digital Repository (Chubanov and
Gudermann, 2016). (1) IPA Canonical Pathways representing differentially expressed genes in the
Chubanov et al. eLife 2016;5:e20914. DOI: 10.7554/eLife.20914 27 of 32
Research article Biophysics and Structural Biology Human Biology and Medicine
liver of Trpm6-deficient mice. (2) IPA Causal Networks for differentially expressed genes in the liver
of Trpm6-deficient mice.
DOI: 10.7554/eLife.20914.023
. Supplementary file 3. Metabolic profiling of the serum, liver and gastrocnemius muscle of Trpm6-
deficient mice. Dataset is available in the Dryad Digital Repository (Chubanov and Gudermann,
2016). (1) Statistical analysis of metabolite measurements in serum samples. (2) Statistical analysis of
metabolite measurements in gastrocnemius muscle samples. (3) Statistical analysis of metabolite
measurements in liver samples. (4) Metabolites significantly changed in serum samples of Trpm6-
deficient mice (FDR p0.05). (5) Metabolites significantly changed in gastrocnemius muscle samples
of Trpm6-deficient mice (FDR p0.05). (6) Metabolites significantly changed in liver samples of
Trpm6-deficient mice (FDR p0.05). (7) Abbreviations of metabolites.
DOI: 10.7554/eLife.20914.024
Major datasets
The following datasets were generated:
Author(s) Year Dataset title Dataset URL
Database, license,
and accessibility
information
Chubanov V, Gu-
dermann T
2015 Whole-genome profiling of the liver
transcriptome in Trpm6 gene
deficient mice and control
littermates
https://www.ncbi.nlm.
nih.gov/geo/query/acc.
cgi?acc=GSE70457
Publicly available at
the NCBI Gene
Expression Omnibus
(accession no:
GSE70457)
Chubanov V, Gu-
dermann T
2016 Data from: Epithelial magnesium
transport by TRPM6 is essential for
prenatal development and adult
survival
http://dx.doi.org/10.
5061/dryad.gs7fv
Available at Dryad
Digital Repository
under a CC0 Public
Domain Dedication
References
Aarts M, Iihara K, Wei WL, Xiong ZG, Arundine M, Cerwinski W, MacDonald JF, Tymianski M. 2003. A key role
for TRPM7 channels in anoxic neuronal death. Cell 115:863–877. doi: 10.1016/S0092-8674(03)01017-1,
PMID: 14697204
Abraham KJ, Chan JN, Salvi JS, Ho B, Hall A, Vidya E, Guo R, Killackey SA, Liu N, Lee JE, Brown GW, Mekhail K.
2016. Intersection of calorie restriction and magnesium in the suppression of genome-destabilizing RNA-DNA
hybrids. Nucleic Acids Research 44:8870–8884. doi: 10.1093/nar/gkw752, PMID: 27574117
Bartke A, Sun LY, Longo V. 2013. Somatotropic signaling: trade-offs between growth, reproductive
development, and longevity. Physiological Reviews 93:571–598. doi: 10.1152/physrev.00006.2012, PMID: 235
89828
Blomen VA, Ma´jek P, Jae LT, Bigenzahn JW, Nieuwenhuis J, Staring J, Sacco R, van Diemen FR, Olk N, Stukalov
A, Marceau C, Janssen H, Carette JE, Bennett KL, Colinge J, Superti-Furga G, Brummelkamp TR. 2015. Gene
essentiality and synthetic lethality in haploid human cells. Science 350:1092–1096. doi: 10.1126/science.
aac7557, PMID: 26472760
Bonnefont JP, Djouadi F, Prip-Buus C, Gobin S, Munnich A, Bastin J. 2004. Carnitine palmitoyltransferases 1 and
2: biochemical, molecular and medical aspects. Molecular Aspects of Medicine 25:495–520. doi: 10.1016/j.
mam.2004.06.004, PMID: 15363638
Brandao K, Deason-Towne F, Perraud AL, Schmitz C. 2013. The role of Mg2+ in immune cells. Immunologic
Research 55:261–269. doi: 10.1007/s12026-012-8371-x, PMID: 22990458
Braun A, Gessner JE, Varga-Szabo D, Syed SN, Konrad S, Stegner D, Vo¨gtle T, Schmidt RE, Nieswandt B. 2009.
STIM1 is essential for fcgamma receptor activation and autoimmune inflammation. Blood 113:1097–1104.
doi: 10.1182/blood-2008-05-158477, PMID: 18941110
Chaigne-Delalande B, Li FY, O’Connor GM, Lukacs MJ, Jiang P, Zheng L, Shatzer A, Biancalana M, Pittaluga S,
Matthews HF, Jancel TJ, Bleesing JJ, Marsh RA, Kuijpers TW, Nichols KE, Lucas CL, Nagpal S, Mehmet H, Su
HC, Cohen JI, et al. 2013. Mg2+ regulates cytotoxic functions of NK and CD8 T cells in chronic EBV infection
through NKG2D. Science 341:186–191. doi: 10.1126/science.1240094, PMID: 23846901
Chubanov V, Gudermann T. 2016. Data from: Epithelial magnesium transport by TRPM6 is essential for prenatal
development and adult surviva. Dryad Digital Repository. doi: 10.5061/dryad.gs7fv
Chubanov V, Waldegger S, Mederos y Schnitzler M, Vitzthum H, Sassen MC, Seyberth HW, Konrad M,
Gudermann T. 2004. Disruption of TRPM6/TRPM7 complex formation by a mutation in the TRPM6 gene causes
hypomagnesemia with secondary hypocalcemia. PNAS 101:2894–2899. doi: 10.1073/pnas.0305252101,
PMID: 14976260
Dawson PA, Rakoczy J, Simmons DG. 2012. Placental, renal, and ileal sulfate transporter gene expression in
mouse gestation. Biology of Reproduction 87:43. doi: 10.1095/biolreprod.111.098749, PMID: 22674389
Chubanov et al. eLife 2016;5:e20914. DOI: 10.7554/eLife.20914 28 of 32
Research article Biophysics and Structural Biology Human Biology and Medicine
de Baaij JH, Hoenderop JG, Bindels RJ. 2015. Magnesium in man: implications for health and disease.
Physiological Reviews 95:1–46. doi: 10.1152/physrev.00012.2014, PMID: 25540137
Ding F, O’Donnell J, Xu Q, Kang N, Goldman N, Nedergaard M. 2016. Changes in the composition of brain
interstitial ions control the sleep-wake cycle. Science 352:550–555. doi: 10.1126/science.aad4821,
PMID: 27126038
Durlach J, Page`s N, Bac P, Bara M, Guiet-Bara A. 2004. New data on the importance of gestational mg
deficiency. Journal of the American College of Nutrition 17:116–125. doi: 10.1080/07315724.2004.10719411,
PMID: 15319145
Erlebacher A, Price KA, Glimcher LH. 2004. Maintenance of mouse trophoblast stem cell proliferation by TGF-
beta/activin. Developmental Biology 275:158–169. doi: 10.1016/j.ydbio.2004.07.032, PMID: 15464579
Essletzbichler P, Konopka T, Santoro F, Chen D, Gapp BV, Kralovics R, Brummelkamp TR, Nijman SM,
Bu¨rckstu¨mmer T. 2014. Megabase-scale deletion using CRISPR/Cas9 to generate a fully haploid human cell
line. Genome Research 24:2059–2065. doi: 10.1101/gr.177220.114, PMID: 25373145
Feeney KA, Hansen LL, Putker M, Olivares-Yan˜ez C, Day J, Eades LJ, Larrondo LF, Hoyle NP, O’Neill JS, van
Ooijen G. 2016. Daily magnesium fluxes regulate cellular timekeeping and energy balance. Nature 532:375–
379. doi: 10.1038/nature17407, PMID: 27074515
Fleig A, Chubanov V. 2014. TRPM7. Handbook of experimental pharmacology 222:521–546. doi: 10.1007/978-3-
642-54215-2_21, PMID: 24756720
Friedman M, Hatcher G, Watson L. 1967. Primary hypomagnesaemia with secondary hypocalcaemia in an infant.
The Lancet 1:703–705. doi: 10.1016/S0140-6736(67)92181-2, PMID: 4163945
Garinis GA, Uittenboogaard LM, Stachelscheid H, Fousteri M, van Ijcken W, Breit TM, van Steeg H, Mullenders
LH, van der Horst GT, Bru¨ning JC, Niessen CM, Hoeijmakers JH, Schumacher B. 2009. Persistent transcription-
blocking DNA lesions trigger somatic growth attenuation associated with longevity. Nature Cell Biology 11:
604–615. doi: 10.1038/ncb1866, PMID: 19363488
Gempel K, Kiechl S, Hofmann S, Lochmu¨ller H, Kiechl-Kohlendorfer U, Willeit J, Sperl W, Rettinger A, Bieger I,
Pongratz D, Gerbitz KD, Bauer MF. 2002. Screening for carnitine palmitoyltransferase II deficiency by tandem
mass spectrometry. Journal of Inherited Metabolic Disease 25:17–27. doi: 10.1023/A:1015109127986,
PMID: 11999976
Gu¨nther T. 2006. Concentration, compartmentation and metabolic function of intracellular free Mg2+.
Magnesium Research 19:225–236. PMID: 17402290
Hayashi S, Tenzen T, McMahon AP. 2003. Maternal inheritance of cre activity in a Sox2Cre deleter strain. Genesis
37:51–53. doi: 10.1002/gene.10225, PMID: 14595839
Jin J, Desai BN, Navarro B, Donovan A, Andrews NC, Clapham DE. 2008. Deletion of Trpm7 disrupts embryonic
development and thymopoiesis without altering Mg2+ homeostasis. Science 322:756–760. doi: 10.1126/
science.1163493, PMID: 18974357
Jin J, Wu LJ, Jun J, Cheng X, Xu H, Andrews NC, Clapham DE. 2012. The channel kinase, TRPM7, is required for
early embryonic development. PNAS 109:E225–E233. doi: 10.1073/pnas.1120033109, PMID: 22203997
King DE, Mainous AG, Geesey ME, Woolson RF. 2005. Dietary magnesium and C-reactive protein levels. Journal
of the American College of Nutrition 24:166–171. doi: 10.1080/07315724.2005.10719461, PMID: 15930481
Konrad M, Schlingmann KP. 2014. Inherited disorders of renal hypomagnesaemia. Nephrology Dialysis
Transplantation 29:iv63–iv71. doi: 10.1093/ndt/gfu198
Kujoth GC, Hiona A, Pugh TD, Someya S, Panzer K, Wohlgemuth SE, Hofer T, Seo AY, Sullivan R, Jobling WA,
Morrow JD, Van Remmen H, Sedivy JM, Yamasoba T, Tanokura M, Weindruch R, Leeuwenburgh C, Prolla TA.
2005. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309:481–
484. doi: 10.1126/science.1112125, PMID: 16020738
Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume
E, Iwasaki H, Iida A, Shiraki-Iida T, Nishikawa S, Nagai R, Nabeshima YI. 1997. Mutation of the mouse klotho
gene leads to a syndrome resembling ageing. Nature 390:45–51. doi: 10.1038/36285, PMID: 9363890
Li FY, Chaigne-Delalande B, Kanellopoulou C, Davis JC, Matthews HF, Douek DC, Cohen JI, Uzel G, Su HC,
Lenardo MJ. 2011. Second messenger role for Mg2+ revealed by human T-cell immunodeficiency. Nature 475:
471–476. doi: 10.1038/nature10246, PMID: 21796205
Lipman RD, Dallal GE, Bronson RT. 1999. Lesion biomarkers of aging in B6C3F1 hybrid mice. The Journals of
Gerontology Series A : Biological Sciences and Medical Sciences 54:B466–B477. doi: 10.1093/gerona/54.11.
B466
Lo´pez-Otı´n C, Blasco MA, Partridge L, Serrano M, Kroemer G. 2013. The hallmarks of aging. Cell 153:1194–
1217. doi: 10.1016/j.cell.2013.05.039, PMID: 23746838
Madison BB, Dunbar L, Qiao XT, Braunstein K, Braunstein E, Gumucio DL. 2002. Cis elements of the Villin gene
control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the
intestine. Journal of Biological Chemistry 277:33275–33283. doi: 10.1074/jbc.M204935200, PMID: 12065599
Maier JA. 2012. Endothelial cells and magnesium: implications in atherosclerosis. Clinical Science 122:397–407.
doi: 10.1042/CS20110506, PMID: 22248353
Marin˜o G, Ugalde AP, Ferna´ndez AF, Osorio FG, Fueyo A, Freije JM, Lo´pez-Otı´n C. 2010. Insulin-like growth
factor 1 treatment extends longevity in a mouse model of human premature aging by restoring somatotroph
axis function. PNAS 107:16268–16273. doi: 10.1073/pnas.1002696107, PMID: 20805469
Milla PJ, Aggett PJ, Wolff OH, Harries JT. 1979. Studies in primary hypomagnesaemia: evidence for defective
carrier-mediated small intestinal transport of magnesium. Gut 20:1028–1033. doi: 10.1136/gut.20.11.1028,
PMID: 527871
Chubanov et al. eLife 2016;5:e20914. DOI: 10.7554/eLife.20914 29 of 32
Research article Biophysics and Structural Biology Human Biology and Medicine
Miller RA, Harrison DE, Astle CM, Floyd RA, Flurkey K, Hensley KL, Javors MA, Leeuwenburgh C, Nelson JF,
Ongini E, Nadon NL, Warner HR, Strong R. 2007. An aging interventions testing program: study design and
interim report. Aging Cell 6:565–575. doi: 10.1111/j.1474-9726.2007.00311.x, PMID: 17578509
Mitchell SJ, Madrigal-Matute J, Scheibye-Knudsen M, Fang E, Aon M, Gonza´lez-Reyes JA, Cortassa S, Kaushik S,
Gonzalez-Freire M, Patel B, Wahl D, Ali A, Calvo-Rubio M, Buro´n MI, Guiterrez V, Ward TM, Palacios HH, Cai
H, Frederick DW, Hine C, et al. 2016. Effects of sex, strain, and energy intake on hallmarks of aging in mice.
Cell Metabolism 23:1093–1112. doi: 10.1016/j.cmet.2016.05.027, PMID: 27304509
Mostoslavsky R, Chua KF, Lombard DB, Pang WW, Fischer MR, Gellon L, Liu P, Mostoslavsky G, Franco S,
Murphy MM, Mills KD, Patel P, Hsu JT, Hong AL, Ford E, Cheng HL, Kennedy C, Nunez N, Bronson R,
Frendewey D, et al. 2006. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6.
Cell 124:315–329. doi: 10.1016/j.cell.2005.11.044, PMID: 16439206
Nadler MJ, Hermosura MC, Inabe K, Perraud AL, Zhu Q, Stokes AJ, Kurosaki T, Kinet JP, Penner R, Scharenberg
AM, Fleig A. 2001. LTRPC7 is a Mg.ATP-regulated divalent cation channel required for cell viability. Nature
411:590–595. doi: 10.1038/35079092, PMID: 11385574
Natale DR, Hemberger M, Hughes M, Cross JC. 2009. Activin promotes differentiation of cultured mouse
trophoblast stem cells towards a labyrinth cell fate. Developmental Biology 335:120–131. doi: 10.1016/j.ydbio.
2009.08.022, PMID: 19716815
Niedernhofer LJ, Garinis GA, Raams A, Lalai AS, Robinson AR, Appeldoorn E, Odijk H, Oostendorp R, Ahmad
A, van Leeuwen W, Theil AF, Vermeulen W, van der Horst GT, Meinecke P, Kleijer WJ, Vijg J, Jaspers NG,
Hoeijmakers JH. 2006. A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph
axis. Nature 444:1038–1043. doi: 10.1038/nature05456, PMID: 17183314
No¨renberg W, Plo¨tz T, Sobottka H, Chubanov V, Mittermeier L, Kalwa H, Aigner A, Schaefer M. 2016. TRPM7 is
a molecular substrate of ATP-evoked P2X7-like currents in tumor cells. The Journal of General Physiology 147:
467–483. doi: 10.1085/jgp.201611595, PMID: 27185858
Palacios-Prado N, Chapuis S, Panjkovich A, Fregeac J, Nagy JI, Bukauskas FF. 2014. Molecular determinants of
magnesium-dependent synaptic plasticity at electrical synapses formed by connexin36. Nature
Communications 5:4667. doi: 10.1038/ncomms5667, PMID: 25135336
Pena MJ, Lambers Heerspink HJ, Hellemons ME, Friedrich T, Dallmann G, Lajer M, Bakker SJ, Gansevoort RT,
Rossing P, de Zeeuw D, Roscioni SS. 2014. Urine and plasma metabolites predict the development of diabetic
nephropathy in individuals with type 2 diabetes mellitus. Diabetic Medicine 31:1138–1147. doi: 10.1111/dme.
12447, PMID: 24661264
Pesta D, Gnaiger E. 2012. High-resolution respirometry: OXPHOS protocols for human cells and permeabilized
fibers from small biopsies of human muscle. Methods in Molecular Biology 810:25–58. doi: 10.1007/978-1-
61779-382-0_3, PMID: 22057559
Quamme GA. 2010. Molecular identification of ancient and modern mammalian magnesium transporters.
American Journal of Physiology: Cell Physiology 298:C407–429. doi: 10.1152/ajpcell.00124.2009, PMID: 1
9940067
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. 2015. Limma powers differential expression
analyses for RNA-sequencing and microarray studies. Nucleic Acids Research 43:e47. doi: 10.1093/nar/gkv007,
PMID: 25605792
Rodushkin I, Engstro¨m E, Stenberg A, Baxter DC. 2004. Determination of low-abundance elements at ultra-trace
levels in urine and serum by inductively coupled plasma-sector field mass spectrometry. Analytical and
Bioanalytical Chemistry 380:247–257. doi: 10.1007/s00216-004-2742-7, PMID: 15322793
Rodushkin I, Odman F. 2001. Application of inductively coupled plasma sector field mass spectrometry for
elemental analysis of urine. Journal of Trace Elements in Medicine and Biology 14:241–247. doi: 10.1016/
S0946-672X(01)80010-9, PMID: 11396785
Romani AM. 2011. Cellular magnesium homeostasis. Archives of Biochemistry and Biophysics 512:1–23. doi: 10.
1016/j.abb.2011.05.010, PMID: 21640700
Rosanoff A, Weaver CM, Rude RK. 2012. Suboptimal magnesium status in the United States: are the health
consequences underestimated? Nutrition Reviews 70:153–164. doi: 10.1111/j.1753-4887.2011.00465.x,
PMID: 22364157
Ryazanova LV, Rondon LJ, Zierler S, Hu Z, Galli J, Yamaguchi TP, Mazur A, Fleig A, Ryazanov AG. 2010. TRPM7
is essential for Mg(2+) homeostasis in mammals. Nature Communications 1:109. doi: 10.1038/ncomms1108,
PMID: 21045827
Saggerson ED. 1982. Carnitine acyltransferase activities in rat liver and heart measured with palmitoyl-CoA and
octanoyl-CoA. latency, effects of K+, bivalent metal ions and malonyl-CoA. Biochemical Journal 202:397–405.
doi: 10.1042/bj2020397, PMID: 7092822
Sah R, Mesirca P, Mason X, Gibson W, Bates-Withers C, Van den Boogert M, Chaudhuri D, Pu WT, Mangoni ME,
Clapham DE. 2013. Timing of myocardial TRPM7 deletion during cardiogenesis variably disrupts adult
ventricular function, conduction, and repolarization. Circulation 128:101–114. doi: 10.1161/CIRCULATIONAHA.
112.000768, PMID: 23734001
Sarac¸ M, O¨nalan E, Bakal U¨, Tartar T, Aydın M, Orman A, Tektemur A, Tas¸kın E, Erol FS, Kazez A. 2016.
Magnesium-permeable TRPM6 polymorphisms in patients with meningomyelocele. SpringerPlus 5:1703.
doi: 10.1186/s40064-016-3395-7, PMID: 27757375
Schlingmann KP, Sassen MC, Weber S, Pechmann U, Kusch K, Pelken L, Lotan D, Syrrou M, Prebble JJ, Cole DE,
Metzger DL, Rahman S, Tajima T, Shu SG, Waldegger S, Seyberth HW, Konrad M. 2005. Novel TRPM6
Chubanov et al. eLife 2016;5:e20914. DOI: 10.7554/eLife.20914 30 of 32
Research article Biophysics and Structural Biology Human Biology and Medicine
mutations in 21 families with primary hypomagnesemia and secondary hypocalcemia. Journal of the American
Society of Nephrology 16:3061–3069. doi: 10.1681/ASN.2004110989, PMID: 16107578
Schlingmann KP, Weber S, Peters M, Niemann Nejsum L, Vitzthum H, Klingel K, Kratz M, Haddad E, Ristoff E,
Dinour D, Syrrou M, Nielsen S, Sassen M, Waldegger S, Seyberth HW, Konrad M. 2002. Hypomagnesemia with
secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nature
Genetics 31:166–170. doi: 10.1038/ng889, PMID: 12032568
Schmitz C, Perraud AL, Johnson CO, Inabe K, Smith MK, Penner R, Kurosaki T, Fleig A, Scharenberg AM. 2003.
Regulation of vertebrate cellular Mg2+ homeostasis by TRPM7. Cell 114:191–200. doi: 10.1016/S0092-8674(03)
00556-7, PMID: 12887921
Schulz S, Lichtmannegger J, Schmitt S, Leitzinger C, Eberhagen C, Einer C, Kerth J, Aichler M, Zischka H. 2015.
A protocol for the parallel isolation of intact mitochondria from rat liver, kidney, heart, and brain. Methods in
Molecular Biology 1295:75–86. doi: 10.1007/978-1-4939-2550-6_7, PMID: 25820715
Schulz S, Schmitt S, Wimmer R, Aichler M, Eisenhofer S, Lichtmannegger J, Eberhagen C, Artmann R, Tookos F,
Walch A, Krappmann D, Brenner C, Rust C, Zischka H. 2013. Progressive stages of mitochondrial destruction
caused by cell toxic bile salts. Biochimica Et Biophysica Acta - Biomembranes 1828:2121–2133. doi: 10.1016/j.
bbamem.2013.05.007
Schumacher B, van der Pluijm I, Moorhouse MJ, Kosteas T, Robinson AR, Suh Y, Breit TM, van Steeg H,
Niedernhofer LJ, van Ijcken W, Bartke A, Spindler SR, Hoeijmakers JH, van der Horst GT, Garinis GA. 2008.
Delayed and accelerated aging share common longevity assurance mechanisms. PLoS Genetics 4:e1000161.
doi: 10.1371/journal.pgen.1000161, PMID: 18704162
Shao X, Somlo S, Igarashi P. 2002. Epithelial-specific cre/lox recombination in the developing kidney and
genitourinary tract. Journal of the American Society of Nephrology 13:1837–1846. doi: 10.1097/01.ASN.
0000016444.90348.50, PMID: 12089379
Simmons DG, Cross JC. 2005. Determinants of trophoblast lineage and cell subtype specification in the mouse
placenta. Developmental Biology 284:12–24. doi: 10.1016/j.ydbio.2005.05.010, PMID: 15963972
Simmons DG, Natale DR, Begay V, Hughes M, Leutz A, Cross JC. 2008. Early patterning of the chorion leads to
the trilaminar trophoblast cell structure in the placental labyrinth. Development 135:2083–2091. doi: 10.1242/
dev.020099, PMID: 18448564
Smyth GK. 2004. Linear models and empirical bayes methods for assessing differential expression in microarray
experiments. Statistical Applications in Genetics and Molecular Biology 3:1–25. doi: 10.2202/1544-6115.1027
Springer ML, Rando T, Blau HM. 2002. Gene delivery to muscle. Boyle AL Current Protocols in Human Genetics.
New York: John Wiley & Sons. doi: 10.1002/0471142905.hg1304s31
Stritt S, Nurden P, Favier R, Favier M, Ferioli S, Gotru SK, van Eeuwijk JM, Schulze H, Nurden AT, Lambert MP,
Turro E, Burger-Stritt S, Matsushita M, Mittermeier L, Ballerini P, Zierler S, Laffan MA, Chubanov V, Gudermann
T, Nieswandt B, et al. 2016. Defects in TRPM7 channel function deregulate thrombopoiesis through altered
cellular Mg(2+) homeostasis and cytoskeletal architecture. Nature Communications 7:11097. doi: 10.1038/
ncomms11097, PMID: 27020697
Tanaka S, Kunath T, Hadjantonakis AK, Nagy A, Rossant J. 1998. Promotion of trophoblast stem cell proliferation
by FGF4. Science 282:2072–2075. doi: 10.1126/science.282.5396.2072, PMID: 9851926
Tin A, Ko¨ttgen A, Folsom AR, Maruthur NM, Tajuddin SM, Nalls MA, Evans MK, Zonderman AB, Friedrich CA,
Boerwinkle E, Coresh J, Kao WH. 2015. Genetic loci for serum magnesium among African-Americans and gene-
environment interaction at MUC1 and TRPM6 in European-Americans: the atherosclerosis risk in communities
(ARIC) study. BMC Genetics 16:56. doi: 10.1186/s12863-015-0219-7, PMID: 26058915
Trifunovic A, Wredenberg A, Falkenberg M, Spelbrink JN, Rovio AT, Bruder CE, Bohlooly-Y M, Gidlo¨f S, Oldfors
A, Wibom R, To¨rnell J, Jacobs HT, Larsson NG. 2004. Premature ageing in mice expressing defective
mitochondrial DNA polymerase. Nature 429:417–423. doi: 10.1038/nature02517, PMID: 15164064
Turturro A, Witt WW, Lewis S, Hass BS, Lipman RD, Hart RW. 1999. Growth curves and survival characteristics of
the animals used in the biomarkers of aging program. The Journals of Gerontology Series A: Biological
Sciences and Medical Sciences 54:B492–501. doi: 10.1093/gerona/54.11.B492, PMID: 10619312
van de Ven M, Andressoo JO, Holcomb VB, von Lindern M, Jong WM, De Zeeuw CI, Suh Y, Hasty P,
Hoeijmakers JH, van der Horst GT, Mitchell JR. 2006. Adaptive stress response in segmental progeria
resembles long-lived dwarfism and calorie restriction in mice. PLoS Genetics 2:e192. doi: 10.1371/journal.pgen.
0020192, PMID: 17173483
van der Pluijm I, Garinis GA, Brandt RM, Gorgels TG, Wijnhoven SW, Diderich KE, de Wit J, Mitchell JR, van
Oostrom C, Beems R, Niedernhofer LJ, Velasco S, Friedberg EC, Tanaka K, van Steeg H, Hoeijmakers JH, van
der Horst GT. 2007. Impaired genome maintenance suppresses the growth hormone–insulin-like growth factor
1 axis in mice with Cockayne syndrome. PLoS Biology 5:e2. doi: 10.1371/journal.pbio.0050002,
PMID: 17326724
van der Vorst EP, Jeurissen M, Wolfs IM, Keijbeck A, Theodorou K, Wijnands E, Schurgers L, Weber S, Gijbels
MJ, Hamers AA, Dreymueller D, Rose-John S, de Winther MP, Ludwig A, Saftig P, Biessen EA, Donners MM.
2015. Myeloid A disintegrin and metalloproteinase domain 10 deficiency modulates atherosclerotic plaque
composition by shifting the balance from inflammation toward fibrosis. The American Journal of Pathology
185:1145–1155. doi: 10.1016/j.ajpath.2014.11.028, PMID: 25659879
Varela I, Cadin˜anos J, Penda´s AM, Gutie´rrez-Ferna´ndez A, Folgueras AR, Sa´nchez LM, Zhou Z, Rodrı´guez FJ,
Stewart CL, Vega JA, Tryggvason K, Freije JM, Lo´pez-Otı´n C. 2005. Accelerated ageing in mice deficient in
Zmpste24 protease is linked to p53 signalling activation. Nature 437:564–568. doi: 10.1038/nature04019,
PMID: 16079796
Chubanov et al. eLife 2016;5:e20914. DOI: 10.7554/eLife.20914 31 of 32
Research article Biophysics and Structural Biology Human Biology and Medicine
Voets T, Nilius B, Hoefs S, van der Kemp AW, Droogmans G, Bindels RJ, Hoenderop JG. 2004. TRPM6 forms the
Mg2+ influx channel involved in intestinal and renal Mg2+ absorption. Journal of Biological Chemistry 279:19–
25. doi: 10.1074/jbc.M311201200, PMID: 14576148
Walder RY, Landau D, Meyer P, Shalev H, Tsolia M, Borochowitz Z, Boettger MB, Beck GE, Englehardt RK, Carmi R,
Sheffield VC. 2002. Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia.Nature
Genetics 31:171–174. doi: 10.1038/ng901, PMID: 12032570
Walder RY, Yang B, Stokes JB, Kirby PA, Cao X, Shi P, Searby CC, Husted RF, Sheffield VC. 2009. Mice defective
in TRPM6 show embryonic mortality and neural tube defects. Human Molecular Genetics 18:4367–4375.
doi: 10.1093/hmg/ddp392, PMID: 19692351
Wang T, Birsoy K, Hughes NW, Krupczak KM, Post Y, Wei JJ, Lander ES, Sabatini DM. 2015. Identification and
characterization of essential genes in the human genome. Science 350:1096–1101. doi: 10.1126/science.
aac7041, PMID: 26472758
Woudenberg-Vrenken TE, Sukinta A, van der Kemp AW, Bindels RJ, Hoenderop JG. 2011. Transient receptor
potential melastatin 6 knockout mice are lethal whereas heterozygous deletion results in mild
hypomagnesemia. Nephron Physiology 117:11–19. doi: 10.1159/000320580, PMID: 20814221
Zhang Y, Xu J, Ruan YC, Yu MK, O’Laughlin M, Wise H, Chen D, Tian L, Shi D, Wang J, Chen S, Feng JQ, Chow
DH, Xie X, Zheng L, Huang L, Huang S, Leung K, Lu N, Zhao L, et al. 2016. Implant-derived magnesium induces
local neuronal production of CGRP to improve bone-fracture healing in rats. Nature Medicine 22:1160–1169.
doi: 10.1038/nm.4162, PMID: 27571347
Zhang Z, Yu H, Huang J, Faouzi M, Schmitz C, Penner R, Fleig A. 2014. The TRPM6 kinase domain determines
the mgATP sensitivity of TRPM7/M6 heteromeric ion channels. Journal of Biological Chemistry 289:5217–5227.
doi: 10.1074/jbc.M113.512285, PMID: 24385424
Zhou H, Clapham DE. 2009. Mammalian MagT1 and TUSC3 are required for cellular magnesium uptake and
vertebrate embryonic development. PNAS 106:15750–15755. doi: 10.1073/pnas.0908332106, PMID: 19717468
Zischka H, Lichtmannegger J, Schmitt S, Ja¨gemann N, Schulz S, Wartini D, Jennen L, Rust C, Larochette N,
Galluzzi L, Chajes V, Bandow N, Gilles VS, DiSpirito AA, Esposito I, Goettlicher M, Summer KH, Kroemer G.
2011. Liver mitochondrial membrane crosslinking and destruction in a rat model of wilson disease. Journal of
Clinical Investigation 121:1508–1518. doi: 10.1172/JCI45401, PMID: 21364284
Chubanov et al. eLife 2016;5:e20914. DOI: 10.7554/eLife.20914 32 of 32
Research article Biophysics and Structural Biology Human Biology and Medicine
